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Abstract 
There is burgeoning interest in the complex tripartite interplays between the commensal 
microbiota, host’s genetic factors, and immune response during helminth infections which are 
still poorly understood. The study explores this relationship in the context of chronic 
schistosomiasis-driven pathology. In the first part of the thesis, removal of the host Basic 
Leucine Zipper ATF-Like Transcription Factor 2 (Batf2) gene in 129Sv (Batf2-/-) mice resulted 
in alteration of the intestinal microbial composition and reduced granulomatous inflammatory 
immune response. These changes associated with rescue from pre-mature mortality and 
improved fitness of Batf2-/- mice during chronic experimental schistosomiasis in relation to 
control wild type mice. The prolonged survival and reduced immunopathology were 
diminished by treatment with α-CD8 antibody highlighting the significance of CD8-expressing 
immune mediators during chronic Schistosomiasis. Transfer of the altered intestinal microbiota 
from Batf2-/- mice to wild type mice by co-housing was enough to rescue the latter from 
exacerbated granulomatous inflammation and prolonged their survival during chronic 
schistosomiasis. These observations suggest, for the first time, a central role of the host gut 
microbiota in decisively regulating the tissue immune response, the elicited pathology and host 
survival during schistosomiasis. To validate the robustness of this tripartite interaction during 
chronic schistosomiasis around the gut microbiota, the second part of the present work analysed 
two genetically identical murine models (C57BL/6) housed under two different specific 
Pathogen free environments (SPF1 and SPF2) and presenting differential susceptibility to 
chronic schistosomiasis. Our work revealed a higher susceptibility of C57BL/6 mice from the 
SPF2 facility in relation to C57BL/6 mice from the SPF1 facility. In confirmation with our 
first series of experiments, that demonstrated a central role of the host intestinal microbiota in 
regulating the immune responses, the pathology, and the survival of the host during 
schistosomiasis, the second series of experiments further presented an ameliorated 
immunological, pathological and vital prognosis of vulnerable SPF2 C57BL/6 mice receiving 
the intestinal microbiota of more resistant SPF1 C57BL/6 mice. Therefore, the study 
demonstrates the genetic regulation of gut microbiota which in turn, and/or in concert with the 
genetic make-up, influence the immunological, pathological, and vital host response during 
chronic schistosomiasis. The present work expands the conventional knowledge on 
schistosomiasis disease regulation and presents the gene-microbiota-immune-response 
interactome as a core piece of the regulatory machinery of this infection as exploitable to alter 
disease progression in the context of drug and vaccine development.  
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1. Literature review 
1.1. Introduction to helminth infections 
Helminths are a group of large and multicellular invertebrates that are either free-living or 
parasitic to other large organisms such as humans. They are characterised by having elongated, 
flat, or rounded bodies (CDC, 2016; Castro et al., 1996). There are three main types of 
helminths which are of clinical relevance to humans, and these include flatworms or 
Trematodes, tapeworms or Cestodes, and roundworms or Nematodes (CDC, 2016; Castro et 
al., 1996). These parasites are highly neglected tropical infectious agents which affect both 
human and animal health, mainly in developing countries that have limited resources (Hotez et 
al., 2008; WHO, 2012). The infections have roamed and parasitized humans since the era of 
humans’ earliest known history and have influenced the course of mammalian life forms (Cox 
et al., 2002; Hotez et al., 2008). The helminth infections result in a disease burden which 
parallels those caused by well-known diseases such as malaria and tuberculosis globally (Hotez 
et al., 2008). They affect over 2 billion people worldwide resulting in morbidities that 
contribute to poverty and inadequate socioeconomic development (Wright et al., 2018; WHO, 
2012). Given that helminth infections are frequently co-endemic with other infections such as 
malaria and HIV/AIDS, they therefore pose an additional indirect global threat in that they 
potentiate these disease conditions as well as tuberculosis (WHO, 2012; Hotez et al., 2008). 
They even reduce the effectiveness of vaccines used a range of infectious diseases (WHO, 
2012). It is therefore crucial to develop and provide more resources through research to combat 
and ultimately reduce the global burden caused by the helminth infections. 
 
1.2. Burden of Helminth infections  
Helminth studies have received little attention compared to other major disease-causing agents 
such as HIV and Mtb, in that only about 1% of global funding is dedicated to research on these 
infections (Hotez et al., 2008), even though they also contribute to the global burden of diseases 
through enhanced poverty and morbidity (Hotez et al., 2006). One of the major impacts of 
helminth infections is on school-aged and pre-school children who most often harbour high 
numbers of intestinal worms and schistosomes. These infections lead to growth impairments, 
reduced physical fitness as well as impairment of cognition and memory from an early age 
(Crompton et al., 2002). The most surprising and poverty-fuelling economic consequence of 
these helminths is poor childhood educational performances, as well as reduced labour outcome 
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leading to continued disadvantaged communities (Miguel et al., 2003). Hookworms and 
schistosomiasis further impact on pregnancy by causing reduced birth weight, neonatal 
prematurity, as well as increased maternal morbidity and mortality (Christian et al., 2004).   
 
1.3. Life cycle  
1.3.1. General life cycle of Helminth infections  
Helminth infections are unique in relation to other agents that are infectious such as viruses, 
bacteria, protozoa, and fungi, in that they develop and complete their life cycle in more than 
one host, and most of them, in their adult form are unable to replicate within human hosts, other 
than the Strongyloides stercoralis (Hotez et al., 2008; Grove et al., 1986). It is because of this 
replication feature that the prevalence of helminths should be considered together with the 
worm intensity/burden to assess the epidemiology of helminths (Hotez et al., 2008). The worm 
burden measures the number of infectious agents that an individual is exposed to, such as the 
number of eggs per gram of faeces or tissue for intestinal helminths and schistosomes, which 
are largely the cause of pathology in infected individuals (Anderson et al., 1982; Grove et al., 
1986; Hotez et al., 2008).  
 
1.3.2. Life cycle of Schistosoma mansoni  
The Schistosoma mansoni (S. manosni), which is the model of infection used in the current 
study, develops within the mammalian host as well as in intermediate snail host of the genera 
Biomphalaria so they can complete their life cycle (CDC, 2019). The parasite’s eggs which are 
eliminated through the host’s faeces, hatch into miracidia in favourable conditions in an aquatic 
environment. These miracidia swim around in search of an intermediary snail host and gain 
entry to develop into sporocysts and then into cercaria. The cercaria which are infective to 
mammals, are then released from the snails and swim around searching for a human host. They 
enter the human hosts through the skin and shed their tails once inside to develop into 
schistosomulae. The schistosomulae then migrate using venous circulation to the lungs, then 
to the heart, and to the portal veins of the liver where they further develop into mature worms. 
The adult worms then migrate to the mesenteric venules where the female and male worms 
copulate resulting in the release of pathogenic eggs that are deposited to small venules of the 
perivesical and portal systems. Lastly, the eggs migrate to the lumen of the intestine where they 
will be expelled in the faeces of the human host (CDC, 2019).    
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1.4. Immune responses 
1.4.1. General host immune responses to Helminth infections 
It is crucial to understand and have knowledge of the helminths that develop within a human 
host, especially their developmental stages which are responsible for pathological changes that 
lead to morbidity and potentially to mortality (Castro et al., 1996). This will improve on 
strategies employed to design more effective drug candidates for the control of helminth 
infections. Considering this, it is also vital to note that the helminth parasites differ in their 
ability to induce pathogenesis in infected hosts. The trematodes which are leaf-shaped, are 
pathogenic in their egg, larva, and adult form, while the tapeworms and nematodes are more 
pathogenic in their larval and adult forms (Castro et al., 1996).  
  
The presence of the pathogenic forms of the parasites induces a more dominant type 2 immune 
response that is also accompanied by Th1 and Th17 responses which all help in clearing the 
parasites from the infected host (Hotez et al., 2008, Hams et al., 2013). The dominant helminth-
induced type 2 immune response is characterized by innate (i.e. eosinophils) and adaptive 
dominant Th2 immune responses that produce key inflammatory cytokines including IL-4, IL-
5, IL-13, and IL-9 in the infected host (Fort et al., 2001; Dillon et al., 2004; McSorley et al., 
2012), while the Th1 and Th17 responses contribute IFN-g, IL-12, TNF-alpha, and IL-17 
inflammatory mediators (McSorley et al., 2012). Additionally, the humoral response through 
the production of IgE, and IgGs, also plays a significant role through their ability to recognize 
helminth antigens and help in the killing and clearance of the parasites from the infected host 
(LoVerde et al., 2019; McSorley and Maizels, 2012).   
 
The inflammatory responses are mainly responsible for the expulsion of adult worms, help 
mediate survival of the infected host upon failure to clear the worms, and mediate a wound-
healing fibro-pathological response that helps the host during chronic infection in order to help 
repair damaged tissues (Wynn et al., 2004; Loke et al., 2007; Finkelman et al., 2004; Hotez et 
al., 2008). Furthermore, the type 2 inflammatory immune response can help prevent survival 
of secondary infecting parasites (Voehringer et al., 2006), although this is not normally 
effective given that the clearance of worms even with the use of drugs, results in a memory 
immune response that fails to protect against re-infection (McSorley et al., 2012). The 
production of the inflammatory immune mediators further contributes to tissue 
immunopathology that results in symptomatic features that are characteristic of helminth 
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infections such as abdominal pain, diarrhoea, malnutrition, and impaired physical development 
(Caldas et al 2008; McSorley et al., 2012; WHO, 2020).  
 
1.4.2. Immune responses to Schistosoma mansoni 
In the case of S. mansoni, the host induces a variety of immune responses which result in 
development of granulomatous inflammation around the trapped eggs ultimately leading to 
hepato-splenomegaly (Caldas et al 2008). The infection induces several phases of 
Schistosomiasis disease as demonstrated in figure 1 with various arms of the host immune 
responses: (i) the initial dormant phase characterized by dominant Th1 response, (ii) the acute 
phase characterized by dominant Th2 response, (iii) as well as the chronic phase that is 
characterized by regulated inflammatory immune response and production of tissue repairing 
fibrosis (McSorley et al., 2012; LoVerde et al., 2019; Dunne and Cooke, 2005).  
 
The initial phase of the infection begins from as early as 1 to 2 weeks upon detection of the 
migrating S. mansoni cercariae and this induces a dominant Th1 response which is 
characterized by the release of INF-γ and IL-12, persisting up to 4- or 5-weeks post infection 
(LoVerde et al., 2019). However, the response is not strong enough to cause any observable 
immunopathology, thus leading to the host being asymptomatic during this phase of infection 
(Hams et al., 2013; LoVerde et al., 2019; McSorley et al., 2012). As the infection progresses 
with the parasites maturing, mating, and releasing eggs within the host, the disease results in a 
temporary increase of pro-inflammatory Th1 response (TNF-a, INF-γ and IL-12). This 
contributes to the development of granulomatous inflammation that is mediated by the 
recruitment and aggregation of multicellular immune mediators such as the eosinophils, 
macrophages, neutrophils, CD4+ T cells, and immunoglobulins as depicted in figure 2 (Hams 
et al., 2013; LoVerde et al., 2019). The presence of the parasite eggs also induces an increase 
in Th2 response with the release of regulatory IL-10 cytokine that causes a decrease in Th1 
response, and also results in the release of inflammatory cytokines including IL-4, IL-5, IL-9, 
and IL-13 which further potentiate the granulomatous inflammation (LoVerde et al., 2019; 
Hams et al., 2013). Although the type 2 response is more dominant, the host also induces other 
inflammatory immune mediators such as the pathogenic Th17 responses with the release of IL-
17 cytokines contributing to the development of granulomatous inflammation (LoVerde et al., 
2019).    
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As the infection progresses, the host further recruits fibroblasts which contributes to a gradual 
increase of fibrosis in the affected tissues (Hams et al., 2013). During week 7 to 8 post infection 
when the dominant Th2 is at its peak, the disease becomes more acute with well-formed 
granulomatous inflammation that, together with the Th2 response, help protect the host against 
the toxic S. mansoni eggs logged into tissues (Hams et al., 2013; LoVerde et al., 2019; Dunne 
and Cooke, 2005). Failure to mount a dominant Th2 response at this phase of infection 
predisposes the host to develop hepatotoxicity, endotoxemia, as well as severe cachexia that 
may all lead to mortality as demonstrated using animal models (LoVerde et al., 2019). The 
acute phase of infection often occurs in tourists and immigrants coming into endemic areas for 
Schistosomiasis and this is due to it being their first exposure to the infecting parasite (Caldas 
et al. 2008; LoVerde et al., 2019). The patients suffering from acute Schistosomiasis develop 
symptoms including malaise, fever, myalgia, eosinophilia, headache, fatigue, as well as 
abdominal pain (Caldas et al. 2008; LoVerde et al., 2019).     
 
As the infection persists in the infected host from week 8 to 12, the dominant Th2 inflammatory 
response is modulated leading to significantly reduced granulomatous immunopathology 
surrounding the parasite eggs (LoVerde et al., 2019). At this point of infection, the newly 
released eggs also induce smaller granulomatous inflammation compared to the ones forming 
during the peak of acute schistosomiasis, and this is driven by well controlled antigen-specific 
T helper cells (LoVerde et al., 2019). Furthermore, the infection also induces a pathogenic 
Th17 that contributes to the development of the granulomatous inflammation through the 
release of IL-17 cytokines (Mbow et al. 2013). The modulated inflammatory immune response 
which also leads to reduced immunopathology is mediated through the action of IL-10 that is 
produced by alternatively activated macrophages and T regulatory cells (Rutitzky and 
Stadecker, 2011; Singh et al., 2005). It has been previously demonstrated that the IL-10 
cytokine is very crucial to allow the transition of the disease from acute to chronic 
Schistosomiasis through modulation of the inflammatory immune responses in an infected host 
(Sadler et al., 2003). However, other studies have also suggested other key immune mediators 
that contribute to regulation of the immunopathology during Schistosomiasis, and these include 
the B cells as well as the type 1 CD8+ T cells (CD8+ IFN-y+ T cells) of which in their absence, 
the host succumbs to exacerbated granulomatous immunopathology (Jankovic et al., 1998; 
Pancreâ et al., 1999; Pedras-Vasconcelo and Pearce, 1996). The chronic phase of 
schistosomiasis through infection intensity, leads to a variety of disease outcomes (LoVerde et 
al., 2019). One form of the disease is known as intestinal Schistosomiasis which causes 
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intermittent abdominal pain, rectal bleeding, and diarrhoea with the symptoms correlated to the 
infection intensity (LoVerde et al., 2019). The second form of the disease is called 
hepatosplenic schistosomiasis which is a life-threatening disease that results in portosystemic 
shunting of venous blood, portal hypertension, severe hepatic as well as periportal fibrosis that 
leads to cirrhosis (LoVerde et al., 2019).    
 
 
Figure 1: A graphical overview of the kinetics of the host immune response and Schistosomiasis mansoni 
disease. (Dunne & Cooke, 2005: Modified drawing by Dunne). 
 
Acute phase Chronic phase
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Figure 2: A graphical representation of type 2 granulomatous inflammation in response to S mansoni eggs. 
(Hams et al., 2013). 
 
1.4.3. Development of immune tolerance during helminth infection 
Immunosuppressive mediators which include IL-10, TGF-β, and the expansion of Foxp3+ T 
cells, all help keep the inflammatory immune responses in check to prevent exacerbated 
immunopathogenesis in an infected host (McSorley and Maizels, 2012). However, they also 
contribute a tolerogenic phenotype through their ability to suppress the pathogen-specific 
immunity resulting in prolonged survival of the infecting parasites within the host (McSorley 
and Maizels, 2012). The helminth infections have taken advantage of this feature to evade the 
immune response, favouring their survival in the infected host. The parasites modify the 
immune responses through their excretory and secretory products which interferes with the 
host’s immunity from the point of pathogen recognition through to the end-stage effector 
mechanisms favouring a more suppressive Th2 response in the host leading to reduced 
Th1/Th17 responses (Hewitson et al., 2009). This feature of the helminths to manipulate 
immune responses predisposes the host to complications from other infectious pathogens that 
are normally controlled through the induction of Th1 immunity such as Mtb and HIV-1 which 
are also prevalent in disadvantaged areas where the helminths are present (Filbey et al., 2018; 
Hewitson et al., 2009; Walson and John-Stewart, 2012; Babu and Nutman, 2016). Therefore, 
the presence of helminths increases the susceptibility of the infected hosts to either HIV-1 or 
Mtb infection which further complicates conditions in already disadvantaged communities 
(Walson and John-Stewart, 2012; Babu and Nutman, 2016).       
 
8 | P a g e  
 
1.5. Control of helminth infections 
1.5.1. General control of helminth infections 
To overcome the complications caused by the helminths, global health systems such as the 
World Health Organization (WHO) have committed themselves to control and eradicate the 
parasites from endemic areas or in infected individuals through roadmaps and implementation 
of guidelines, policies and strategies that help combat these pathogens (WHO, 2012). Among 
the guidelines set out by the WHO, there are 6 key measures implemented for the control of 
helminth infections: 1, Intensified case-detection and case management - which focuses on 
principal strategies used for managing helminth infections that have no medicines to help 
prevent infection. This approach involves (i) early diagnosis of the pathogens, (ii) managing 
complications that are caused by the pathogen, (iii) providing treatment to reduce the infection 
and morbidity. 2, Vector and intermediate host control - which is one of the strategies employed 
using pesticides to control for insects or aquatic snails that serve as intermediary hosts that 
facilitate the transmission and persistence of the helminths in endemic areas.  3, Veterinary 
public health at the human-animal interface - this includes activities implemented at the human-
animal interface which addresses human and animal health to help prevent, eliminate and 
control suffering as well as economic loss that is caused by the helminths. 4, Provision of safe 
water, sanitation, and hygiene – this includes programs aimed at providing safe and adequate 
water as well as ensuring appropriate sanitation in endemic areas since the helminths also thrive 
in poorly maintained environments. 5, Strengthening capacity to control helminths or rather 
neglected tropical diseases (NTD) - this focuses on providing essential skills that will help in 
effectively managing the national NTD control programmes that will address the limited 
expertise and knowledge needed in areas such as vector control, pesticide management, case 
management, as well as veterinary public health. 6, Preventative chemotherapy - which is 
aimed at using large-scale, single dose and safe medicines to significantly reduce extensive 
morbidities that result from the helminths infections. The approach makes use of larger scale 
administration of anti-helminthic medicines such as Praziquantel for use against Schistosoma 
and flukes (WHO, 2012; WebMD, 2019). Although this drug is widely used and effective at 
treating Schistosomiasis in infected individuals, it has limitations which include the induction 
of drug resistance in clinical settings, its mode of action is targeted at adult worms and not the 
pathogenic eggs which are responsible for the immunopathogenesis observed in infected 
individuals (Stelma et al., 1995; Ismail et al., 1999). The drug has also been reported to be 
ineffective in T or B cell deprived mice indicating that immunosuppressed individuals may be 
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at higher risk of succumbing to the Schistosomiasis-induced morbidity and potentially 
mortality especially in cases of co-infections (Sabah et al., 1985; Brindley et al., 1987). 
Furthermore, the individuals that are infected with helminths such Schistosoma develop 
chronic inflammatory disorders which result in delayed-onset pathology in infected hosts and 
unfortunately the drug treatment lacks the therapeutic potential to reverse schistosomiasis-
induced pathology (Hotez et al., 2008; Nono et al., 2020). Therefore, complemental 
therapeutics or strategies aimed at reversing the helminth-induced pathology are required to 
enhance the protective mechanism against invading pathogens.      
 
1.5.2. Host-directed-drug therapy for the control of helminth-induced immunopathology 
The complementary strategies to deal with helminth-induced pathology are possible through 
host-directed therapy (HDT) which involves targeting of host molecules that are utilized by 
pathogens to survive in an infected host (Kaufmann et al., 2018). Such approaches have 
recently been more focused on research associated with bacterial and viral infections to 
overcome resistance against antimicrobial agents as well as to restrict host tissue damage 
(Kaufmann et al., 2018). There have also been recent advancements in the use of HDT in 
helminth infections targeting host factors to reverse and overcome helminth-induced pathology 
and protect the infected host (Nono et al., 2017; Andrews et al., 2006; Nono et al., 2017). Some 
of these advancements have extensively focused on understanding the role of the host IL-4Rα 
as a possible target for therapeutic invention in helminth infected individuals (Nono et al., 
2017). This is because the IL-4Rα is an important mediator for type 2 immune responses that 
are critical to drive the control of helminth infections as well as associated immunopathology 
(Hams et al., 2013; LoVerde et al., 2019; Nono et al., 2017). The IL-4 and IL-13 are key 
cytokines which signals through this receptor to coordinate type 2 immune responses during 
helminth infections, and in the study by Nono et al., 2017, this receptor was demonstrated to 
be a crucial target for the regulation of liver fibroproliferative pathology as well as Th2 
response in Schistosoma mansoni infected mice. Furthermore, the receptor was also 
demonstrated to be required to sustain and help recall the protective immunity to other helminth 
infections such as the Nematodes (Nono et al., 2017). Studies like these demonstrate the 
potential of using HDT as a complimentary strategy for the control of helminth infections and 
the resultant pathology.     
 
Among the host factors with the potential to control Schistosoma-induced immunopathogenesis 
is the Basic leucine transcription factor 2 (Batf2). This transcription factor has recently gained 
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attention in both type 1 and type 2 diseases as a potential target for infectious diseases (Guler 
et al., 2018; Guler et al., 2015; Mpotje, 2017).  The transcription factor belongs to a group of 
family members that contain basic leucine zipper domains which help them regulate and 
control the differentiation of immune cells and thus regulate various immunological functions 
(Guler et al., 2015). Furthermore, the Batf family members lack the transactivation domain and 
therefore need to form heterodimer with other transcription members that poses the 
transcription domain to be active (Murphy et al., 2013). They normally form heterodimers with 
members of the activator protein 1 (AP-1) regulatory domains such the JUN and FOS which 
have an additional carboxyterminal domain containing the transactivation domain that the Batf 
family members lack (Murphy et al., 2013).  
 
The Batf2 is unique from the other Batf family members as it also has an additional carboxy 
terminal domain like other AP-1 family members (Murphy et al., 2013), hinting that the 
transcription factor may have more unexplored potential functions that may be crucial for 
therapeutic strategies against infections. The Batf2 was initially thought to be an AP-1 inhibitor 
given that it was demonstrated to prevent DNA binding of AP-1 complex molecules through 
the interaction with JUN protein leading to suppression of growth and apoptosis in tumour cells 
(Su et al., 2008; Liu et al., 2015). Furthermore, it was demonstrated to play a vital role of 
suppressing the expression of IL-23 leading to inhibited Th17 immunopathological response 
during Trypanosoma cruzi infection (Kitada et al., 2018). However, recent studies have also 
demonstrated the transcription factor to act as a transcriptional activator, especially in 
classically activated macrophages through interaction with IRF1 leading to increased 
inflammatory responses during mycobacterium infection (Roy et al., 2015). Given this role, 
the transcription was therefore, suggested as a potential biomarker and target for the 
development of host directed therapy against Mtb infections (Guler et al., 2015).   
 
1.5.3. The role of Batf2 during acute Schistosomiasis  
The study which preceded the current one, has also demonstrated the significance of Batf2 
during acute Schistosomiasis (Mpotje, 2017). In the study, the transcription factor was shown 
to be crucial for the control of Schistosomiasis-induced inflammatory responses during the 
acute phase mainly in the small intestine leading to regulated small intestinal immunopathology 
that in turn promotes hosts survival during the infection. It was interesting to note that the 
absence of Batf2 resulted in increased fibro-granulomatous immunopathology in the small 
intestine but not the liver, and this indicated the potential of the transcription factor to have a 
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tissue specific role during Schistosomiasis (Mpotje, 2017). This phenomenon could potentially 
be attributed to a dimer it interacts with, either the JUN or IRF1 dimer which influences the 
batf2’s role to act as either a suppressor or activator of transcription, depending on the disease 
(Guler et al., 2015; Murphy et al., 2013; Mpotje, 2017). Since the Batf2 plays a significant 
regulatory role during acute Schistosomiasis when the inflammatory immune response is more 
dominant and crucial to protect against the S. mansoni eggs (Hams et al., 2013; Mpotje, 2017), 
it is possible that the inflammatory response is regulated through the improved activity of Batf2 
during chronic Schistosomiasis leading to reduced immunopathology. Considering what is 
known about the Batf2, the transcription factor could be a key target for therapeutic inventions 
for the control of infectious diseases, especially Schistosoma mansoni that has been 
demonstrated to be controlled through this transcription factor (Mpotje, 2017).   
Since Batf2 acts as either an inhibitor or activator of transcription (Murphy et al., 2013), the 
choice of targeting the host factor will need to be disease specific. This means in the case of 
Mtb infection where the transcription factor is associated with inducing inflammatory 
responses against the bacteria (Roy et al., 2015), the design of a host-directed therapy based on 
Batf2 will be using drug candidates or compounds that bind to receptors such as Jak1/2, TLR2, 
or TLR4 which have been reported to induce activation of Batf2 (Roy et al., 2015). 
Alternatively, the Batf2 can be targeted using drug inhibitors which would block binding of 
the transcription to other heterodimers (IFR1 or JUN) to prevent transcriptional activation or 
suppression of a Batf2-target gene (Murphy et al., 2013) in diseases that are worsened by the 
presence of the transcription factor. Since Batf2 has dual roles during Schistosomiasis, the 
choice of targeting the transcription factor during the disease will need to be phase/time-
dependent, i.e., Given that a previous study has demonstrated that the Batf2 is required during 
acute phase of Schistosomiasis (Guler et al., 2019) and not required during chronic 
Schistosomiasis, the drug inhibitors against Batf2 will need to be administered in hosts that 
have developed the chronic Schistosomiasis. On the other hand, hosts that have developed 
acute Schistosomiasis will need to be administered with drug inhibitors against natural 
competitors of Batf2 binding such as ATF-2 motif which would potentially allow for increased 
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1.6. Commensal Microbiota 
1.6.1. Introduction to microbiota 
Mammalian hosts also harbour a variety of microorganisms comprised mainly of bacteria, 
viruses, fungi, and protozoans which all form the microbiota (Tlaskalová-Hogenová et al., 
2011). This microbiota partakes to the induction of the immune response to protect from 
pathogens that invade hosts (Wu et al., 2012; Turnbaugh et al., 2006). The host develops a 
healthy relationship with the microbiota early in life leading to a well-maintained tissue 
homeostasis (Cardin et al., 2015). The bacteria, estimated to be around 3x 1013, constitute a 
large number compared to other microbes and for this reason, most microbiome-wide 
association research studies (MWAS) have focused on understanding the composition and 
association of the bacteria in relation to disease within the host they inhabit (Sender, R. et al. 
2016; Surana and Kasper, 2017). Furthermore, the microbiotas are generally symbiotic and 
help mediate metabolic functions which involves energy harvesting from food, therefore 
providing essential nutrients and vitamins such as amino acids and short-chain fatty acids to 
their hosts (Cardin et al., 2015). They also regulate physiological components such as the 
immune response as well as behaviour (Surana and Kasper, 2017).   
 
1.6.2. Factors influencing microbiota composition. 
The composition of microbial communities is believed to be initially shaped following 
maternal transmission during birth as foetuses are sterile in utero. However, there are studies 
which have reported the umbilical cord blood (Jime´nez et al., 2005), the placenta tissue 
(Aagaard et al., 2014), and amniotic fluid (Jime´nez et al., Bearfield et al., 2002; 2008; Rautava 
et al., 2012) as well as in foetal membranes (Steel et al., 2005; Rautava et al., 2012) to contain 
bacteria which all suggest that the in utero is not as sterile as previously believed (Martinez-
Guryn et al., 2018; Rodrı´guez et al. 2015). The microbial community is therefore pioneered 
from the foetal development and is further influenced during birth, infancy, adult, and old age 
as depicted in figure 3 (Martinez-Guryn et al., 2018; Rodrı´guez et al. 2015). Moreover, during 
infancy the microbiota is influenced by several factors which include geographical location, 
environment, breastfeeding vs formula, genetics, complementary food, and duration of 
lactation (Rodrı´guez et al. 2015). In adults the composition of the intestinal microbiota is 
largely influenced by diet and lifestyle which, once established, remain relatively stable 
(Rodrı´guez et al. 2015). In elders, the composition is also influenced by diet and lifestyle, as 
well as medication as depicted in figure 3. However, the intestinal microbiota can be altered 
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by several factors which include lifestyle, infections, long-term changes in diet, as well as 
antibiotic treatment and medication (Rodrı´guez et al. 2015).     
 
Figure 3. Development of intestinal microbiota in infants, adults, and elders (Rodrı´guez et al., 2015). 
 
1.6.3. Association of host genetics and microbiota composition 
Even though the composition of microbiota is predominantly affected by environmental 
factors, the Microbiome Genome-wide Association Studies (mMWAS) have demonstrated an 
association that exists between common traits (BMI or height) and many genetic variants in 
human host (Visscher et al., 2012; Weissbrod et al., 2018). They have also shown, using 
monozygotic (MZ) and dizygotic (DZ) twins that some bacterial taxa are heritable. All these 
suggests that the host genetics do in part influence the intestinal microbiota (Polderman et al., 
2015; Goodrich et al., 2016; Wang et al., 2016; Turpin et al., 2016). Interestingly, a study by 
O’Connor et al, 2014, profiled 8 ancestral mice strains (129S1/SvImJ; C57BL/6J; A/J; NZO/ 
HILtJ; NOD/ShiLtJ; PWK/PhJ; CAST/EiJ; WSB/EiJ) using 16 rRNA to compare the enteric 
microbial communities under the same diet as well under a different diet. Their studies revealed 
that some microbial communities were strain-specific and were even retained under different 
diets indicating that their presence was associated with the host genetics (O’Connor et al, 
2014).    
 
1.6.4. Influence of altered microbiota (Dysbiosis) 
The alterations to microbial compositions, also termed as dysbiosis, are associated in many 
cases, with triggering local and systemic inflammation (Cardin et al, 2015; Marchesi et al., 
2016). Within the intestine, dysbiosis results in severe disorders such as irritable bowel 
syndrome (IBS), inflammatory bowel disease (IBD), and coeliac, as well as other disorders 
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resulting from outside the intestine which include asthma, allergy, metabolic syndrome, 
obesity, and cardiovascular disease (Cardin et al., 2015). Although the composition of the 
microbiota which can be classified as healthy is not yet fully known – and appears to be disease-
specific, many MWAS have shown that some species of bacteria are normally associated with 
healthy microbiota (Zaiss et al., 2015; Cardin et al., 2015) while some constitute unhealthy or 
bad microbiota (Blanton et al., 2016; Cardin et al., 2015). Some species of the bad microbiota 
have also been associated and implicated as potential biomarkers of disease (Surana and 
Kasper, 2017).   
 
Given that the immune system has developed alongside the commensal microbiota, this co-
existence has resulted in the development of a tolerogenic immune response that can tolerate 
the presence of the microbiota in a host (Reynolds et al., 2015). The host has also developed 
mechanisms which allows it to identify the presence of harmless, pathogenic and as well as 
beneficial microbes which enables an appropriate response to each type of microbe (Hooper et 
al., 2012; Reynolds et al., 2015). Tolerance to these microbes is achieved through activation of 
suppressive regulatory T cells which would inhibit Th1/Th17 effector responses against the 
microbes (Reynolds et al., 2015). The induction of the suppressive regulatory T cells is a 
common feature for both the microbiota as well as the intestinal helminth parasites to enable 
their colonisation within a host (Geuking et al., 2011; Yazdanbakhsh et al. 2001; Maizels and 
Smith, 2011). The presence of these microbes, both the microbiota and the helminths, have 
beneficial significance within the host in that they mediate amelioration of autoimmune 
diseases (Kostic et al., 2014; Wen et al., 2008; McSorley et al., 2012).  
 
1.7. Association of Helminths and microbiota  
Although the helminths may target and regulate the host immune response to ensure they 
survive, their presence also results in changes to the microbial composition and function 
(Reynolds et al., 2015). This was seen in studies that demonstrated that the chronic H polygyrus 
infection was able to induce an increase in abundance of bacterial species such as 
Enterobacteriaceae and Lactobacillaceae in the small intestine of mice (Reynolds et al., 2014; 
Walk et al., 2010; Rausch et al., 2013;). Similar studies have also shown chronic Trichuris 
muris infection to result in reduced bacterial diversity within the Bacteroidetes phylum and 
increased abundance in the Lactobacillaceae family members (Houlden et al., 2015; Holm et 
al., 2015). Schistosomiasis disease was also shown to induce a significant increase of bacterial 
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abundance from within the Prevetella genus in a cohort of children that were infected from 
Zimbabwe (Kay et al., 2015). Interestingly, treatment with anti-helminthic drugs did not have 
any effect on the microbial composition and this indicated that the parasites have long term 
effects on the changes in microbial composition (Kay et al., 2015). Furthermore, the presence 
of helminth infections also induces the release of excretory secretory products that influences 
an increase in production of antimicrobial peptides which alters the microbial compositions 
within a host (D’Elia et al., 2009; Su et al., 2014). Another important feature within the host is 
the induction of mucosal IgA from the lamina propria plasma cells, and it is responsible for the 
containment of the intestinal microbiota (Macpherson et al., 2012).     
 
Conversely, the gut microbiota also helps the helminth infections allowing for their successful 
colonization within mammalian hosts (Hayes et al., 2010). This was shown using germ-free 
mice which resulted in less persistence of H polygyrus in relation to conventional mice, 
indicating the need for the commensal microbiota during the infection (Weinstein et al., 1969; 
Wescott, 1968). Furthermore, the use of antibiotic treatment in conventional mice even without 
reducing the microbial load, was enough to alter susceptibility of the mice to H. polygyrus 
(Reynolds et al., 2014). Some of the microbes have a beneficial relationship to the persistence 
of helminths and for this reason, the helminths themselves have developed mechanisms to 
selectively enhance for bacterial species that help promote their resistance within the host 
(Houlden et al., 2015; Holm et al., 2015). The beneficial microbes that are selected by the 
helminths can inhibit type 2 immune responses through TLR signalling pathways, thus 
allowing the survival of helminths in the host (Reynolds et al., 2012; Dea-Ayuela et al., 2008; 
Reynolds et al., 2014; Helmby and Grencis, 2003). The significance of the gut microbiota was 
also demonstrated during Schistosoma mansoni infection where administration of broad-
spectrum antibiotics to reduce gut bacteria, resulted in reduced intestinal granulomatous 
inflammation even though the liver was not affected (Holzscheiter et al., 2014). The 
demonstrated that the commensal bacteria can act as bystander activators of the intestinal 
immune response during Schistosomiasis (Holzscheiter et al., 2014). All these highlight the 
significance of microbiota in contributing to health, therefore providing new attractive avenues 
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2. Aim and objectives of the study. 
The aim of the study was to explore and identify the interrelationship between gut, the host 
genetic factor Batf2 and the immune response during chronic Schistosomiasis. The first part of 
the project was focusing on understanding the interrelationship of a host genetic factor (Batf2) 
on both the microbiota and host immune response during chronic schistosomiasis using murine 
models. The second part of the project then focused further on the relationship between the 
microbiota and host’s immune responses to chronic Schistosomiasis infection using murine 
models.   
Part 1: The role of the Basic leucine zipper transcription factor ATF-like 2 (Batf2) in the 
regulation of immunopathology during chronic Schistosomiasis.      
1. Assessment of Batf2 gene dynamics  
2. Assessment of Batf2 gene deletion on susceptibility of mice during chronic Schistosomiasis 
3. Assessment of intestinal microbiota in the absence of Batf2 on susceptibility of mice during 
chronic Schistosomiasis 
 
Part 2: The role of the intestinal microbiota in the regulation of immunopathology during 
chronic Schistosomiasis. 
1. Assessment of the susceptibility of genetically identical mice housed under two different 
specific-pathogen-free facilities.  
2. Assessment of intestinal microbiota of genetically identical mice housed under two 
different specific-pathogen-free facilities.  
3. Assessment of antibiotic treatment in resistant C57BL/6 mice during chronic 
Schistosomiasis. 
4. Comparative analysis of the intestinal microbiota profiles of the genetically identical 
susceptible and resistant mice.   
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3. Materials and Methods 
3.1. Ethics statement  
Ethical clearance for use of experimental mouse models approved by the University of Cape 
Town Animal Ethics Committee was used to conduct all experiments outlined in the study 
under protocol numbers 018/029 and 016/027.  
3.2. Mice   
The mice that were used in the study were housed and maintained in specific pathogen-free 
facility using ventilated cages containing sterile wood shavings for bedding, in Biosafety level 
2 (BSL2) facility of the University of Cape Town. Each cage was housing a maximum of 8 
mice. The experimental work was conducted according to the recommendations from the 
University of Cape Town and South African national guidelines for use of procedures for 
handling of laboratory animals. All efforts were performed to reduce suffering on the animals. 
A total of 110 wildtype C57BL/6 mice from a specific pathogen free 1 facility, 110 wildtype 
C57BL/6 mice from a specific pathogen free 2 facility, and 220 of 129SvEV (Batf2+/+ and 
Batf2-/-) mice purchased from the Jackson laboratory lab were used for the experiments. A 
sample size of 10 mice per group was utilized in each experiment with a percentage power of 
95% and an effect size of 2.5 using a one tail t test. These were to potentially detect with 
confidence a difference between two independent means that will provide a significance level 
of p < 0.05 as calculated using a statistical tool called G. power 3.0.10 (Franz Faul, Universitat 
Kiel, Germany). Each experiment included both male and female mice aging between 7 and 10 
weeks, and the animals were sex and age matched across each group of interest using an initial 
body weight of approximately 15 grams. Furthermore, the animals were subjected to the same 
food source containing a similar diet with a decontaminated water source.   
3.3. Maintenance of S. mansoni life cycle  
The S. mansoni parasites were maintained and expanded using both Biomphalaria glabrata 
snails and the BALB/c female mice which were monitored in a Bio-Safety level 2 facility, 
University of Cape Town. 
3.4. Chronic S. mansoni infection  
A total of 20 wildtype and 20 Batf2 knockout mice were used for chronic mortality study. The 
mice were infected percutaneously with a low dose of 35 S. mansoni cercariae to establish a 
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chronic infection of Schistosomiasis which occurs from week 10 post infection. Mice were sex 
and age matched.  
3.5. Study design 
 
Figure 4: Establishment of faecal transfer between experimental (Batf2-/-) and control WT groups, and 
induction of chronic Schistosomiasis infection using 35 live S. mansoni cercariae.  
 
 
Figure 5: Establishment of faecal transfer between C57BL/6 mice from Specific Pathogen Free (SPF) 1 
facility and those from SPF2 facility, and induction of chronic Schistosomiasis infection using 35 live S. 
mansoni cercariae. 
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The study was performed to include 4 groups as depicted in figure 4 and 5. Figure 4 shows an 
outline of (I) control group (Wildtype); (II) experimental group 1 (Batf2-/-); (III) experimental 
group 2 (wildtype co-housed with Batf2-/-); and experimental group 3 (Batf2-/- co-housed with 
wildtype). Figure 5 shows C57BL/6 from (I) Specific Pathogen Free 1 (SPF1) facility, (II) 
Specific Pathogen Free 2 (SPF2) facility, (III) SPF1 co-housed with SPF2, (III) SPF2 co-
housed with SPF1. Faecal pellets were collected at 4 different time points (7 days prior 
infection, day 1, week 8, and week 10 post infection) to allow characterization of intestinal 
microbiota composition in each of the 4 groups mentioned above. 
The primary experimental outcome assessed from the study was mortality of chronically 
infected mice. During the onset of the experiments the mice were monitored daily and weighed 
weekly until each mouse reached an experimental endpoint which was determined by loss of 
more than 20% body weight, and loss of strength as evidenced by inability to move or grip on 
metal bar cage.  
The secondary experimental outcome assessed include behavioural and immunological 
changes where mice were euthanized during week 10 post infection and the following samples 
were collected for further analysis: Blood, liver, small intestine, mesenteric lymph node 
(MLN), and lung. Each of the experiments were independently conducted at least 2 times with 
a sample size of 10 mice per group in each experiment. The sample sizes were determined 
using G. power 3.0.10 statistical tool to detect significance level of p < 0.05.   
3.6. Collection of samples and analysis  
3.6.1. Blood collection from euthanized mice  
Approximately 500 - 600μl of blood was drawn from each euthanized mouse using cardiac 
puncture with insulin syringe and collected using blood collection tubes (yellow capped tubes) 
containing anti-coagulant. The collected blood was centrifuged for 20 minutes at 8000 rpm to 
separate out serum from whole blood.  
3.6.2. Egg count  
From small intestine, liver and lung tissue 
The worm burden from each mouse was calculated by quantifying the number of eggs present 
in each tissue affected by the S. mansoni parasites as follows; each tissue sample was first 
weighed and recorded prior to processing. The samples were then transferred into 15 mL falcon 
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tubes containing 5 mL of 5% potassium hydroxide (KOH) and incubated at 37°C incubator 
overnight. The samples were then centrifuged for 10 minutes at 2000 rpm and 3 mL of the 
supernatant was discarded for the small intestine and the lung to ensure a total volume of 2ml 
remained in each tube. The samples were then re-suspended by vortex. An aliquot of 50µl was 
used to calculate the number of s. mansoni eggs present in each sample using an inverted 
microscope. The total number of eggs in each sample was then calculated to determine egg 
burden. 
3.6.3. Quantification of fibrosis levels in liver and small intestinal tissues  
Hydroxyl-proline levels in small intestinal and liver tissues were quantified to determine the 
levels of fibrosis in the tissues.  Each tissue sample was weighed and recorded prior to 
processing. The samples were then transferred into 15 mL falcon tubes containing 5 mL of 6M 
Hydrochloric acid (HCl) and were incubated overnight at 110°C incubator. The tubes were 
then topped up with distilled water up 10 mL and then mixed by vortex. From each sample 2 
mL was filtered through a Whatman No.1 filter paper into a new 15 mL falcon tube and then a 
1% of phenolphthalein in ethanol was added to the filtrate. A few drops of 10M sodium 
hydroxide (NaOH) were added into the filtrate until a colour change (from brown to pink) was 
observed, and then a few drops of 3M HCl were added to allow colour change back to light 
brown. The resulting titrate was topped up with distilled water up to 4 mL and 200µl of solution 
was transferred into a new 15 mL falcon tube. Hydroxyl-proline standards were prepared in a 
2-fold dilution series using 9x15mL falcon tubes with a starting concentration of 200µg/ml. 
Four hundred microliters of isopropanol were added into all the tubes including the prepared 
standards and then mixed by vortex. Two hundred microliters of solution A were added, and 
the samples were then incubated at room temperature for 10 minutes. Furthermore, 2.5 mL of 
solution B was also added, and the samples were then added into a 60°C water-bath to incubate 
for 25 minutes. The samples were then immediately cooled on ice then an aliquot of 200µl 
from each sample was transferred into 96 well flat bottom plate (Nunc International, USA). 
The concentrations of hydroxyl-proline in each sample were determined by measuring the 
absorbance of the aliquoted samples on a wavelength of 558nm (excitation) and 570 nm 
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3.6.4. Quantification of enzymes (ALT and AST) associated with tissue toxicity levels. 
The serum samples obtained were diluted by 1:20 using sterile 0.9% Saline solution and then 
submitted to the National health Laboratory Services for further analysis on the levels of ALT 
and AST enzymes using commercially available Biochemical diagnostic kits BIO-LA-TEST 
(Erba Lachema s.r.o). Briefly, a 250μl of AST substrate (0,1 mol/l phosphate buffer at pH 7,4; 
0,1 mol/l L-aspartate; 2 mmol/l 2-oxoglutarate) was added into Eppendorf tube and incubated 
for 3 minutes in 37 °C. Following the incubation, 50μl of serum sample was added while the 
control tube received 50μl of saline and were all incubated for 60 minutes in 37 °C. A 250μl 
of 2,4-DNPH was then added into sample & control tubes and were then allowed to stand for 
20 minutes at room temperature. Lastly, 2.5ml of Sodium hydroxide was also added into the 
sample & control tubes and were then incubated at room temperature for 10 minutes. The 
absorbance of the samples was read at 510nm against the control tubes.  
3.6.5. Histological analysis 
The liver and small intestinal samples were fixed in neutral buffered formalin solution and then 
processed. About 5μm sections were stained with haematoxylin and eosin (H&E) or 
Chromotrope aniline blue (CAB) staining. The diameters of each granuloma that had a single 
egg were quantified using a computerized morphometry analysis program. The egg diameter 
was subtracted from the diameter of the whole granuloma. A total of 100 granulomas per group 
of mice were measured for analysis. Quantification of CAB from each tissue sample (Liver and 
small intestine) was determined using computerized morphometry analysis program to 
determine the intensity of each staining as a measure of tissue fibrosis.  
3.6.6. Liver and small intestinal homogenate preparation for cytokine testing 
The samples were thawed on ice and 500μl of extraction buffer (1X PBS buffer with 0.1% 
Tween and 0.02µm/ml of protease inhibitor) was added to each of the samples. The samples 
were then homogenized using 5mm stainless steel bead for 5 minutes with break intervals after 
each 30 seconds (10x 30 seconds) allowing the samples to be completely homogenized. 
Another 500μl of the extraction buffer was added and the samples centrifuged at 4800 rpm for 
5 minutes in a 4°C. The supernatant was transferred into new labelled 2mL Eppendorf tubes 
and the protein content of each sample was quantified using BCA assay (Thermo Scientific, 
USA. Catalog number 23225) according to the manufacturer’s instructions.   
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3.6.7. ELISA for cytokine measurement   
Cytokine responses were measured in serum, liver, and small intestinal homogenates from non-
infected and infected mice. Ninety-six well plates (Nalge Nunc International, USA) were 
coated with primary capture antibodies specific for each cytokine of interest. The capture 
antibodies diluted in 1X PBS buffer were used. 
The plates were then incubated overnight in 4°C fridge, and then washed with wash buffer (20g 
KCl, 800g NaCl, 20g KH2HPO4.2H2O, 50ml Tween-20, dissolved in 5 litres, then diluted 1:20 
in ddH2O) 3 times. About 200μl of blocking solution containing 2% of milk powder was added 
and then incubated for 2 hours in 37°C to block the coating antibodies. The plates were washed 
5 times with wash buffer and then 50μl of samples were added together with recombinant 
standards for each cytokine tested into the plates. In the case of TGF-β, 48μl of samples plus 
2μl of 1M HCl pH 3 was added and left to incubate for 1 hour in 4°C. The reaction was stopped 
by adding 2μl of 1M of NaOH. All the plates were incubated overnight in 4°C. The recombinant 
proteins were used as standards.  
Following overnight incubation, the plates were again washed 5 times with wash buffer. 
Secondary biotinylated antibodies were then added to the appropriate plates for each of the test 
cytokines and the plates incubated for 2 hours in 37°C. The plates were then washed 5 times 
using wash buffer and then strep-avidin substrate conjugated with either alkaline phosphatase 
(AP) was added in 1/1000 dilution. The plates were then incubated in 37°C for 1 hour and then 
washed again 5 times using wash buffer. The plates were then developed by adding 1mg/ml of 
4 Nitro-phenyl phosphate disodium salt hexahydrate (PNP) (Merck, Germany) diluted in AP 
substrate buffer into each well of the plates. The plates were incubated for 10 minutes in 37°C 
to allow for colour development in positive samples, and the optical density (OD) was 
quantified on a VERSAmax microplate reader (Molecular devices, USA) to determine the 
cytokine concentrations in each sample.  
3.6.8. MLN single cell preparation for Flow cytometry analysis  
Mesenteric Lymph Nodes were collected in 2 mL Eppendorf tubes containing 1mL of Iscove’s 
Modified Dulbecco’s Medium (IMDM) (Gibco, USA) that was supplemented with 10% heat 
inactivated Fetal Bovine Serum (iFBS) (Roche Diagnostics, Germany) and 0.5% Penicillin-
Streptomycin (Pen-strep) (Gibco, USA). Each sample was teased through a 70μm sieve 
(Thermo Scientific, USA) on a petri-dish. The solution was collected and sieved further 
through 40μm sieve into a new labelled 50ml tube, and then topped up to 5ml total solution. 
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The samples were centrifuged for 10 minutes at 1200 rpm and the resultant supernatant was 
discarded.  Five millilitres of medium (IMDM supplemented with 0.5% Pen-strep and 10% 
iFBS) was used to re-suspend the samples. The cells were then counted using 2% trypan blue 
using 1 in 20 dilution.   
3.6.9. Liver, lung, and small intestinal single cell preparation for Flow cytometry analysis 
Liver and small intestinal samples were initially collected in 15ml tubes containing ice-cold 
5mL medium IMDM supplemented with 0.5% Pen-strep and 10% iFBS. The samples were 
placed on a petri-dish and chopped into small pieces then placed into 15ml tube containing 
5mL digestion buffer (IMDM supplemented with 5% iFBS, plus 50 U/ml Collagenase I or II 
(Sigma, USA), plus 13μg/ml DNase (Thermo Scientific, USA). The samples were then placed 
inside a 37°C incubator with a shaker for 30 minutes. Following the incubation, the samples 
were sieved through a 100μm sieve on a petri-dish and sieved again through a 70μm sieve into 
a new labelled 50ml tube. The samples were again centrifuged at 1200 rpm for 10 in a 4°C and 
the supernatant was discarded. Three millilitres of 1X PBS + 3% foetal calf serum (FCS) was 
used to re-suspend the samples and 1.7ml of isotonic percoll (9ml percoll + 1ml of 10X PBS) 
was added, and then mixed thoroughly by inverting the tubes gently. The tubes were 
centrifuged at 500g in 4°C without brakes for 10 minutes. The supernatants were carefully 
removed from the tubes and 5ml of red blood cell (RBC) lysis buffer was used to re-suspend 
the samples, then incubated for 10 minutes at room temperature. Five millilitres of medium 
(IMDM supplemented with 0.5% Pen-strep and 10% iFBS) was added to the solutions and then 
centrifuged for 10 minutes at 1200 rpm in 4°C. The supernatants were carefully removed, and 
the samples were re-suspended in 1mL of medium (IMDM supplemented with 0.5% Pen-strep 
and 10% iFBS). The cells were quantified using 1 in 2 dilution with 2% of trypan blue.   
3.6.10. Flow cytometry            
From the single cell suspensions obtained, a total of 2 million cells in 200μl medium (IMDM 
supplemented with 0.5% Pen-strep and10% iFBS) was added into a V bottom 96 well plate 
(Nalge Nunc International, USA) and then centrifuged at 15 000 rpm for 5 minutes. The cells 
were then re-suspended in a staining antibody cocktail containing FACS buffer (0.02 % NaN3 
and 0.1% BSA in 1x PBS buffer), 2% heat inactivated rat serum (iRS), 1% FcƴRIII plus surface 
antibody markers of interest. The samples were incubated for 30 minutes in 4°C fridge. 
Following incubation, 200μl of FACS buffer was added to wash the cells and then centrifuged 
at 15 000 rpm for 5 minutes. The supernatants were then discarded, and the samples were re-
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suspended in 100μl of FACS buffer for acquisition on LSR Fortessa (BD Immuno-cytometry 
system, USA). 
3.7. Anti-CD8 treatment/administration to Batf2-/- mice during chronic S. mansoni 
infection.  
The WT and Batf2-/- mice were percutaneously infected with a dose of 35 S. mansoni cercariae 
to induce chronic Schistosomiasis. At the beginning of 7 weeks post infection, the Batf2-/- mice 
were treated with 200ug of α-CD8 antibodies 4x every 3rd day to neutralize the CD8+ T cells 
in the knockout mice. The study made used of an already well characterized, unequivocally 
specific and robustly established set of antibodies (Rolot et al., 2018) which were consistent 
with reported proceedings of the literature (Jung et al., 2018; Czuprynski and Brown, 1990; 
Adams et al., 1993; Cano et al., 2000). The mice were monitored until they reached the 
experimental endpoint. The α-CD8 treated Batf2-/- mice were compared to the untreated Batf2-
/- mice during the chronic Schistosomiasis.  
3.8. Bacterial community profiling 
3.8.1. Serum bacterial profiling   
The bacterial profile from serum samples were submitted to Biomedical Diagnostics (BioDoc, 
Germany) for serological analysis using Immunofluorescence Assay (IFA). Briefly, 20μl of 
each serum sample were fixed to multiwell microscope slide and fixed by heating for 20 
minutes in 60 °C thermo-stated plate. Following the fixation, 20μl of diluted antiserum solution 
was applied to the window of each slide. The slides were first rinsed with IF-Buffer-Tween 
(0.1% Tween 20-, and 10-mM phosphate buffered saline (PBS) at pH 7.2) and then washed 2 
times for 7 minutes using IF-Buffer (10 mM phosphate buffered saline (PBS) at pH 7.2). Sterile 
water was then used to rinse and remove excess moisture from the slides. The slides were 
applied with 20μl of secondary labelled antibody and were incubated for 30 minutes in the dark 
at room temperature. The slides were again rinsed with IF-Buffer-Tween, and then washed 2 
times with IF-Buffer for 7 minutes. Once the slides were washed, 10μl of phosphate buffered 
glycerol were added into each window of the slides and a cover slip was applied. These slides 
were examined using an epifluorescence microscope.   
3.8.2. Antibiotic treatment  
SPF1 C57BL/6 mice were orally administered with an antibiotic cocktail containing 0.8mg of 
Amoxicillin 1.7mg of enrofloxacin, 2mg neomycin, and 2mg ampicillin dissolved in sterile 
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water which were previously reported to be effective at reducing broad spectrum of bacteria 
(Marx, et al., 2014; Bayer et al., 2019; Slate et al., 2014; Andes and Craig, 1998; Kennedy et 
al., 2018). The SPF1 C57BL/6 mice were given the cocktail for 14 days then followed by co-
housing with the SPF2 C57BL/6 mice. Following the co-housing, the SPF1 C57BL/6 mice 
were further treated with the antibiotic cocktail for 7 days making a total of 21 days pf treatment 
for the SPF1 C57BL/6 to ensure reduction in bacterial growth as much as possible (Figure 6). 
Following the 21 days of antibiotic treatment, the mice were percutaneously infected with a 
dose of 35 live S. mansoni cercariae to establish a chronic infection and monitored until mice 
reached their experimental endpoint (Figure 6). 
 
 
Figure 6: Figure illustrating the administration of antibiotic cocktail to SPF1 C57BL/6 mice before and 
following co-housing with SPF2 C57BL/6 mice. 
 
3.8.3. Stool sample collection and DNA extraction 
Faecal samples were collected freshly from mice 8 weeks after percutaneous infection with S. 
mansoni as these animals defecate and the faeces directly collected in tubes were immediately 
frozen at -20ºC until use. Bacteria DNA was extracted from the samples using commercially 
available kit, the Powersoil isolation kit (Mobio Laboratories). Briefly, each bacterial pellet 
weighing between 50 to 100mg was added into a ZR BashingBeadTM Lysis Tube (0.1 mm & 
0.5 mm) containing 750μl BashingBeadTM Buffer. The tubes were processed for 20 minutes 
using a bead beater. The tubes were then centrifuged for 1 minute at 10 000xg. From the 
resultant supernatant, 400μl was transferred to Zymo-SpinTMIII-F Filter in a Collection Tube 
and was then centrifuged at 8 000 xg for 1 minute. Following the centrifuge, 1200μl of 
Genomic Lysis Buffer was added to the filtrated in the collection tubes. From the mixture, 
800μl was filtered through Zymo-SpinTM IICR Column in a collection Tube at 10 000 xg for 
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1 minute. This step was repeated twice while discarding the flow through. A 200μl of DNA 
Pre-Wash Buffer was filtered through Zymo-SpinTM IICR Column in a collection Tube at 
10 000 xg for 1 minute. Following the wash step, 900μl g-DNA Wash Buffer was also filtered 
through Zymo-SpinTM IICR Column in a collection Tube at 10 000 xg for 1 minute. The 
Zymo-SpinTM IICR Column was transferred to a clean 1.5ml Eppendorf tube and the DNA 
was eluded from the column by filtering DNA Elution Buffer directly through the column 
matrix at 10 000 xg for 1 minute to elute the DNA. Final DNA concentration was quantified 
by the Picogreen dsDNA HS kit (Invitrogen, UK).   
3.8.4. 16SrRNA gene sequencing 
DNA sequencing targeting the V6 region was performed using extracted DNA. Briefly, the V6 
hypervariable region which belongs to the 16S rRNA gene was multiplied using two step PCR 
procedure: the initial step involved barcoding of the samples while the following step involved 
adding Illumina paired-end sequencing adapters (Caporaso et al., 2011). The amplicons that 
were generated from the PCR were then purified using the Qiagen 96 well purification kit 
(Qiagen, CA). The Quanti-It dsDNA BR assay (Invitrogen, UK) was used to quantify the 
concentrations of the amplicons and 50ng from each was pooled together into one tube. The 
DNA which was pooled was then ran on A 1.5% agarose gel was used to run and visualize the 
pooled DNA. Using the gel purification kit (Qiagen, CA), a band of 330 bp was cut out 
carefully from the gel and purified. The final DNA concentration was then quantified, and 
sequencing of the libraries was done from both ends on the Illumina HiSeq platform.    
3.8.5. Quantification of faecal bacteria   
Faecal bacterial communities in antibiotic treated mice as well as control groups, were 
quantified using tryptic soy ager (TSA) plates as well as tryptic soy broth (TSB) media to assess 
the effectiveness of the antibiotic cocktail used in the study. The faecal bacterial communities 
in experimental groups were analysed to measure their differences in the test groups. A faecal 
pellet from each mouse was collected under sterile conditions into sterile 1.5ml Eppendorf 
tube. The weights of each pellet collected were measured to ensure each pellet is resuspended 
with appropriate volume of 1x PBS to obtain a concentration of 50mg/ml. The samples were 
mixed well using a P1000 pipette and 10ul of the suspension was transferred into a new 
Eppendorf tube containing 990ul sterile 1x PBS to make a 1/100 dilution from the suspension 
(figure 7). The plating was then done by adding 50ul of the 1/100 solution into a TSA plate and 
spread evenly across the plate under sterile conditions (figure 8). The plates were then 
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incubated for 16 hours in 37℃ incubator. From each concentrate (50mg/ml suspension) of the 
initial tubes, 2x50ul were transferred into 2x15ml falcon tubes containing 2ml TSB media 
(figure 7). One falcon tube from each sample was allowed access to atmospheric oxygen by 
not closing the lid properly, while the other tube was deprived of oxygen by closing the lid 
properly. The samples were then incubated for 16 hours in a 37℃ incubator with the oxygen 
fed tubes left on a shaker. Following the incubation, the OD of the TSB samples were measured 














Figure 8: Plating of faecal bacteria on TSA plate. 
 
3.9. RNA extraction  
RNA extraction was done using RNA elute Column protocol (Qaigen kit). Briefly, 1ml of 
sample was supplemented with 200µl of chloroform and mixed vigorously by shaking up and 
down. The sample were then incubated at room temperature for 3 minutes. Again, the samples 
were vigorously mixed and then centrifuged at 10 000 rpm for 15 minutes in a 4°C microfuge. 
 




200mg/ml conc. 1ml of 1xPBS 
50ul 
10ul 
2ml TSB broth 
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A colourless upper aqueous layer was displaced into a new 2mL tube. Then 1mL of 70% 
ethanol was then added and mixed by pipetting up and down. Seven hundred microliters of the 
sample were transferred into a RNeasy spin column that was placed in 2mL collection tube. 
The samples were centrifuged at 10 000 rpm for 15 seconds and 700µl of RW1 buffer was 
added to the spin column placed in a clean 2mL collection tube. The samples were then 
centrifuged for 15 seconds at 10 000 rpm and 500µl of RPE buffer was added to the spin 
column. The samples were further centrifuged for 2 minutes at 10 000 rpm and the spin 
columns were transferred to clean 2mL tube. From the spin column, 30µl of nuclease free water 
was added and the samples were centrifuged at full speed for 1 minute. RNA was quantified 
using a nanodrop ND1000 (Thermo Scientific).   
3.10. cDNA synthesis 
Following the RNA extraction, cDNA synthesis was performed by reverse transcribing the 
RNA samples using Transcriptor First Strand cDNA Synthesis Kit (Roche). Random hexamer 
primer and anchored oligo dT primers were used to reverse transcribe the RNA samples 
according to the manufacturer’s instructions. The mixture of template-primer was denatured 
through heating the tubes for 10 minutes at 65°C in a thermal block cycler (BioRad PTC-100), 
and then followed by first strand synthesis using the following conditions: 25°C for 10 minutes, 
50°C for 60 minutes, 80°C for 5 minutes, and the PCR reaction was then be stopped by placing 
the tubes on ice for 5 minutes.    
3.11. Quantitative Polymerase chain reaction 
Real-time qPCR was performed using Light Cycler® 480 SYBR Green I Master mix in Light 
Cycler® 480 II (Roche). GAPDH was used as a housekeeping gene to normalise the expression 
of batf2. The primer sequences used were as follows, 5′-CTCCTCCTGTTCGACAGTCAGC-
3′ (sense), and 5′-CCCAATACGACCAAATCCGTT-3′ (antisense) for GAPDH and 5′-
AGACCCCAAGGAGCAACA-3′ (sense), and 5′-CTTTTTCCAGAGACTCGTGCT-3′ 
(antisense) for BATF2.  
3.12. Statistical analysis  
The sample size for each experiment performed in the study was a minimum of 6 mice per 
group, and this was determined based on the observation from previous experiments from our 
group which have shown a high variation between individuals within each group which made 
it difficult to pick differences unless a higher number was used per group. The selected sample 
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size gives an expected variability/variation of measured values of 30 with a statistical power of 
0.8. The significance threshold was determined to be 0.05. The GraphPad Prism v 6.0 was used 
to analyse most data, and the statistical tests used included student t-distribution (one-tailed) 
for bar graphs, while the survival curves were analyzed using Log-rank (Mantel-Cox). Means 
were shown as ± SEM.  *, ** and *** indicating P < 0.05, P < 0.01 and P < 0.001, respectively. 
The microbiota data were analysed using Wilcoxon rank and Kruskal-Wallis test and p values 














4. Part 1 of results:   
 
The role of the Basic leucine zipper transcription factor ATF-like 
2 (Batf2) in the regulation of immunopathology during chronic 
Schistosomiasis.       
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4.1. Introduction 
The aim of this study was to explore the influence of host and microbial factors in the 
susceptibility of mice to helminth infections. For this a two-model system was designed (figure 
9) which also allowed the exploration of the interrelationship between a host’s factor (Batf2), 
gut commensal microbiota, as well as the immune response in the context of controlling chronic 
Schistosomiasis disease in murine models.   
A 
B 
Figure 9: Tripartite model system to explore the interrelationship between host’s genetic factor (Batf2), 
commensal microbiota, and immune responses to control helminth infection.  
The figure 9A illustrates a graphical overview of the tripartite interrelationship between the host’s genetic factor 
Batf2, commensal microbiota, and Immune responses against helminth infection. While figure 9B illustrates a 
murine model-system used to study and explore the interrelationships between host’s genetic factor Batf2, 
commensal microbiota, and the Immune responses, with model 1 showing mice that were different in their genetic 
component batf2, which was previously shown to play a key role in driving immune system that is crucial during 
schistosomiasis disease (Mpotje, 2017). The model 2 on the other hand included mice of the same genetic 
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background but with differential microbial composition. This model was used to explore the effect of microbiota 
during chronic schistosomiasis.   
 
4.2. Batf2 deficient mice have improved pathological profiles and prolonged 
survival during chronic S. mansoni infection.   
4.2.1.  Batf2 expression dynamics in tissues during murine schistosomiasis. 
The role of Batf2 during Schistosomiasis was demonstrated using Batf2 deficient mice which 
at homeostasis did not have any major physiological impairments except for minimal changes 
in immune cells’ distributions in the small intestine in relation to the control WT mice (Guler 
et al 2018; Mpotje, 2017). The mice had comparable organ (liver, lung, spleen, heart) weights 
as well as their associated cellular counts with no observable effect on the tissue damage as 
measured by ALT and AST enzymes (Guler et al., 2018). Although, the immune profiles of 
the liver and the lung were not affected by the removal of Batf2, in the small intestine there 
were elevated levels of immune cells as well as cytokines indicating that the removal of Batf2 
was associated with altered intestinal immune response (Guler et al 2018; Mpotje, 2017). The 
current study further explored the intestinal tissue for more changes associated with the 
transcription factor as well as the observed changes in immune profile. Given that the intestinal 
tissue harbours a great number of commensal bacteria which also plays a significant role of 
priming the immune system (Wu et al., 2012; Turnbaugh et al., 2006), faecal pellets were 
analysed using 16S rRNA sequencing. Removal of the Batf2 did not affect the species richness 
(alpha diversity) in the mice (figure 10A), however, there was a different clustering (figure 
10B) and abundance (figure 10C) of the bacteria indicating differences in microbial 
composition in Batf2-/- mice in relation to the WT mice. Despite the observed alterations of 
intestinal immune profile and microbiota, the overall fitness of the mice was not affected during 
homeostasis (Guler et al 2018; Mpotje, 2017). However, the effects of these alterations were 
potentiated during acute Schistosomiasis as evidenced by increased intestinal 
immunopathology as well as reduced survival in the absence of Batf2 (Guler et al 2018). 
Furthermore, the mice retained expression of Batf2 in the intestine hinting that the transcription 
factor potentially plays a vital regulatory role in the tissue during homeostasis and upon acute 
Schistosomiasis (Guler et. al, 2018).  
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Figure 10: Removal of Batf2 alters the composition of intestinal microbiota of 129Sv mice. 
Faecal pellets were collected from Wild-type (129Sv) mice that were 8 weeks old with no complications. (A) 
Boxplot of alpha diversity measurement using Shannon index estimator for the faecal microbial communities from 
WT and Batf2-/- mice. (B) Principal component analysis (PCA) and beta diversity of microbial community 
compositions in WT and Batf2-/- mice. (C) Heatmap of relative abundance of microbial communities at a phylum 
level in S. mansoni infected WT and Batf2-/- mice. WT, n = 8; Batf2-/-, n = 8   analysed as 4 samples per group. 
The comparisons of the graphs were performed by student t test. *p value< 0.05 and **p value < 0.01.  
 
The previous study reported a maintained expression of Batf2 in the small intestinal tissue 
while in the liver, the expression was significantly increased during acute schistosomiasis 
(Guler et al., 2018). Despite the reported increase in expression of Batf2, removal of this 
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transcription factor did not affect the tissue immunopathology during acute Schistosomiasis 
(Guler et. al, 2018). This, therefore, demonstrated a tissue specific role for the Batf2 which was 
most critical to help control the intestinal immunopathology during acute Schistosomiasis. 
Interestingly, the expression of Batf2 in the liver was still significantly increased during a 
chronic phase of the infection in relation to naïve mice (figure 11). It was, however, unclear 














Figure 11: Increased expression of Batf2 mRNA in the liver during chronic S. mansoni infection when 
compared to naïve mice.  
Wild-type (129Sv) mice were percutaneously infected with a low dose of 35 S. mansoni cercaria and sacrificed 
at week 0, and 10 post infection. The levels of Batf2 mRNA were measured in the liver of naïve, and chronic S. 
mansoni infected mice to compare the expression levels of Batf2 at week 0, and 10 (chronic phase) post S. mansoni 
infection. Data represents two experiments conducted independently (n = 7-10). The comparisons of the bar 
graphs were performed by student t test. *p value < 0.05 and **p value < 0.01. 
 
4.2.2. Batf2 gene deletion prolongs mice survival during chronic S. mansoni infection. 
Given that the Batf2 mRNA expression in one of the most highly affected organs (liver) was 
significantly increased during chronic S. mansoni infection in relation to naïve mice, it was 
hypothesised that the transcription factor was potentially contributing a crucial role for the 
survival of S. mansoni infected mice. To test this, wild-type (WT) and Batf2-/- mice were 
percutaneously infected with a low dose of 35 S. mansoni cercariae to introduce a chronic 
infection in the mice. Interestingly, removal of Batf2 resulted in improved survival of the mice 
in relation to the control (WT) mice (figure 12A), and the differences in susceptibility observed 
 
35 | P a g e  
 
were not caused by the worm burden as evidenced by similar S. mansoni egg counts in liver 
tissues of both Batf2-/- and WT mice (figure 12B). This highlighted a potentially significant 
detrimental role that the transcription factor may be playing during chronic Schistosomiasis in 
infected hosts, and therefore, supports the idea of exploring further the Batf2 for its therapeutic 
potential during infections such as S. mansoni infection.   
Figure 12: Removal of Batf2 prolongs survival of the mice during chronic S. mansoni infection.  
The survival of Batf2-/- mice was compared to that of WT mice during chronic S. mansoni infection (A). 
Quantification of S. mansoni eggs comparing the worm burden between WT and Batf2-/- mice during the infection 
(B). Data represents three experiments conducted independently (n = 7 - 12). Comparisons of the survival curves 
were performed by Logrank test. The comparisons of the bar graphs were performed by student t test. *p value < 0.05 
and **p value < 0.01. 
 
4.2.3. Batf2 gene deletion ameliorates tissue immunopathology in mice during chronic S. 
mansoni infection. 
The following objective was to find out the effect of removing Batf2 on the pathogenesis of 
mice during chronic S. mansoni infection which contributed to prolonged survival of the mice. 
The tissue organs that are associated with S. mansoni infection which include liver, lung, 
spleen, and the small intestine were analysed to identify the role of this transcription factor on 
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4.2.3.1. Removal of Batf2 results in reduced liver granulomatous immunopathology during 
chronic S. mansoni infection. 
Given that the primary organs that are normally affected by S. mansoni infection include the 
liver and small intestine, further analysis was done to assess the immuno-pathological features 
that were associated with these organs during the infection in relation to the role of Batf2. The 
histopathological analysis of formalin-fixed liver tissue stained with H&E (figure 13A) 
together with granuloma measurements (figure 13B) showed a significantly reduced 
granulomatous inflammatory response in the absence of Batf2 during chronic S. mansoni 
infection. Further analysis showed an increase in CAB staining (figure 13C) as well as in 
hydroxyproline levels in Batf2-/- mice in relation to the WT mice (figure 13D) which together 
indicated increased hepatic fibrosis that has a primary role of repairing incurred tissue damage 
during the infection (Kamdem, 2018). Altogether, these data indicate that the removal of Batf2 
results in improved regulation of liver immunopathology during chronic Schistosomiasis 
disease.  
Figure 13: Removal of Batf2 results in reduced liver granulomatous immunopathology during chronic S. 
mansoni infection.  
Batf2-/- and WT mice were infected percutaneously with a low dose of 35 S. mansoni cercariae and analysed at 
week 10 post infection. The liver sections fixed in formalin were stained with H&E for morphological analysis of 
the egg-surrounding granuloma (200x) (A). Granuloma measurements quantified using microscopic analysis from 
H&E-stained sections (B). Liver sections fixed in formalin were stained with CAB staining for morphological 
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analysis of fibrosis development in the liver of infected mice (200x) (C). Fibrosis measurements quantified using 
hydroxyproline assay on liver tissues (D). Data represents two experiments conducted independently (n = 7-10). 
The comparisons of the bar graphs were performed by student t test. *p value < 0.05 and ** p value < 0.01.  
4.2.3.2. Removal of Batf2 results in reduced small intestinal tissue granulomatous immunopathology 
during chronic S. mansoni infection.  
Following analysis of the liver pathology, the small intestinal tissue was also analysed as the 
second majorly affected tissue that contributed to increased susceptibility of the Batf2-/- mice 
during acute schistosomiasis as previously reported (Guler et al., 2018; Mpotje, 2017). The 
histopathological analysis of formalin-fixed small intestinal tissue stained with H&E (figure 
14A) together with tissue cellular counts (figure 14B) showed a significantly reduced 
granulomatous immunopathology in the absence of Batf2 during chronic S. mansoni infection. 
Further analysis on the tissue showed an increase in CAB staining (figure 14C) as well as in 
hydroxyproline levels (figure 14D) which together indicated increased small intestinal fibrosis 
in the absence of Batf2. The observed increase in fibrosis was potentially a mechanism 
mediated by the infected host to repair the incurred damage in the small intestinal tissue during 
Schistosomiasis disease. Furthermore, the observed differences in small intestinal pathology 
were not a result of worm burden as evidenced by similar egg counts between Batf2-/- and WT 
mice (figure 14E). Therefore, the absence of Batf2 also results in reduced granulomatous 
immunopathology in the small intestinal tissue during chronic S. mansoni infection like what 
is observed in the liver pathology.    
 
 
38 | P a g e  
 
 
Figure 14: Removal of Batf2 results in reduced small intestinal tissue 
granulomatous immunopathology during chronic S. mansoni infection. 
Formalin-fixed small intestinal sections stained with H&E for morphological 
analysis of the cellular recruitment around the trapped S. mansoni eggs (200x) 
(A). Quantification of small intestinal cell counts (B). Formalin fixed small 
intestinal sections stained with CAB staining for morphological analysis of 
fibrosis development in the small intestinal of infected mice (200x) (C). 
Fibrosis measurements quantified using hydroxyproline assay on liver tissues 
(D). Quantification of S. mansoni egg counts (E). Data represents two 
experiments conducted independently (n = 7-10). The comparisons of the bar graphs were performed by student 
t test. *p value < 0.05 and **p value < 0.01. 
 
4.2.3.3. Removal of Batf2 results in reduced immunopathology of spleen and lung during 
chronic S. mansoni infection.  
The removal of Batf2 did not influence the weight indices of liver, lung, and heart (figure 15A 
- C). However, this absence of Batf2 resulted in reduced spleen index (figure 15D) in relation 
to WT mice. This indicated a reduced schistosomiasis-induced splenomegaly in the Batf2-/- 
mice during chronic S. mansoni infection. Similar to what was observed in acute 
schistosomiasis as previous reported (Mpotje, 2017), the small intestinal length was still 
increased in Batf2-/- mice in relation to WT mice during chronic S. mansoni infection (figure 
15E). Further analysis, revealed that the enzymes (ALT and AST) that are associated with 
tissue cytotoxicity between the WT and Batf2-/- mice were not affected (figures 15F, G). 
However, there was a moderate redution in the levels of AST in the Batf2-/- mice in relation to 
the WT mice during the infection (figure 15G). Even though, the lung weight measurements 
were not different between WT and Batf2-/- mice, the tissue cellular count was modetely 
reduced in Batf2-/- mice indicating a potential reduction in cellular infiltration to the organ and 
thus may have caused a reduction in inflammatory response in Batf2-/- mice (figure 15H). 
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Altogether, it is evident that the absence of Batf2 results in reduced immunopathology of the 
spleen and lung that is also associated with reduced tissue toxicity during chronic S. mansoni 
infection.    
 
Figure 15: Removal of Batf2 results in reduced immunopathology of the spleen and lung during chronic S. 
mansoni infection. 
Batf2-/- and WT mice were infected percutaneously with a dose of 35 S. mansoni cercariae and analysed at week 
10 post infection. Liver (A), lung (B), heart (C), and spleen (D) weight were measured during chronic S. mansoni 
infection. Small intestinal lengths in centimetres were measured during the infection. Serum levels of enzymes 
associated with tissue toxicity, ALT (F) and AST (G), were also measured. Quantification of lung cellular count 
(H).  Data represents two experiments conducted independently (n = 7-10). The comparisons of the bar graphs 
were performed by student t test. *p value < 0.05 and **p value < 0.01.  
 
The current data show that the removal of Batf2 promotes protection against chronic S. mansoni 
infection that was associated with significantly reduced tissue immunopathology. Although the 
immunopathology in both the liver and small intestinal tissues were regulated, there was 
however, increased fibrosis, which was believed to be a mechanism that the infected Batf2-/- 
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speculated that the presence of Batf2 might be detrimental to the infected mice by potentiating 
granulomatous immunopathology during chronic Schistosomiasis.  
 
4.2.4. Altered immune responses in tissues of Batf2-/- mice during chronic Schistosomiasis.  
4.2.4.1. Liver immune responses in Batf2-/- mice during chronic S. mansoni infection. 
The immune profile that was associated with the reduced liver granulomatous 
immunopathology along with increased fibrosis during chronic S. mansoni infection was 
explored. The absence of Batf2 resulted in significantly reduced lymphocyte recruitment i.e.  
CD19+ B and CD4+ T lymphocytes (figure 16A). Other myeloid cells were also of diminished 
representation in the liver tissue i.e., eosinophils, neutrophils, and dendritic cells (figure 16B) 
which all participate to the hepatic granulomatous inflammation that develops around the 
trapped S. mansoni eggs. Although both WT and Batf2-/- mice were dominated by a Th2 
immune response (figure 16C, D), there was a significant decrease in overall polarization of 
CD4+ T cells into Th1 (T-bet), and Th2 (Gata3) subtypes in Batf2-/- mice.  Regulatory (Foxp3) 
CD4+ T cells were also moderately decreased in Batf2-/- mice in relation to the WT mice 
(figure 16C). In the case of CD8+ T cells, polarization into Th1 (T-bet) and Th2 (Gata3) was 
moderately reduced while the regulatory (Foxp3) subtypes were not affected in the Batf2-/- 
mice in relation to WT mice during the infection (figure 16D). Further analysis showed a 
reduction in IL-4 and IL-5 producing CD4+ and CD8+ T cells in Batf2-/- mice in relation to 
WT mice (figure 16E, F). Although, the IFN-γ and IL-13 producing CD4+ T cells in these 
mice were not affected in relation to the WT mice (figure 16E), the CD8+ T cells producing 
these cytokines (IFN-γ and IL-13) were significantly increased in the Batf2-/- mice in relation 
to the WT mice (figure 16F). More analysis of the overall tissue specific cytokines in the liver 
using ELISA revealed that there was a significant increase of IFN-γ and IL-10 cytokines in 
Batf2-/- mice in relation to WT mice (figure 16G, H). The TNF-α cytokine production was also 
significantly reduced in Batf2-/- mice in relation to WT mice during the infection (figure 16G). 
Although, there was a significant increase in inflammatory mediators including IL-5 and IL-
17 cytokines (figure 16G, H) during the infection, the recruitment of type 2 immune 
populations that contribute to hepatic granulomatous immunopathology were reduced in Batf2-
/- mice in relation to WT mice during chronic S. mansoni infection.    
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Figure 16: Removal of Batf2 results in reduced recruitment of type 2 immune populations to the liver 
during chronic S. mansoni infection. 
Batf2-/- and WT mice were percutaneously infected with a dose of 35 S. mansoni cercariae and the immune 
responses were analysed in the liver tissue during week 10 post infection. Quantification of immune cellular 
populations analysed using flow cytometry (A, B). Quantification of CD4+ (C) and CD8+ (D) T lymphocyte 
polarization during the infection analysed using flow cytometry. Quantification of cytokine producing CD4+ (E) 
and CD8+ (F) T lymphocytes re-stimulated with PMA/Ionomycin and analysed on flow cytometry.  Liver 
cytokine concentrations per gram of tissue measured using ELISA (G, H). Data represents two experiments 
conducted independently (n = 7-10). The comparison of bar graphs was made using student t test. *p value < 0.05 
and **p value < 0.01.  
 
4.2.4.2. Intestinal immune response in Batf2-/- mice during chronic S. mansoni infection. 
Next, the immune profile that was associated with the observed immunopathology of the small 
intestinal tissue during chronic S. mansoni infection was explored. In the mesenteric lymph 
nodes (MLN) of Batf2-/- mice, the CD4+ T cells were significantly decreased while the CD8+ 
T cells were moderately increased in relation to WT mice during chronic S. mansoni infection 
(figure 17A). In terms of the myeloid populations recruited in the small intestinal tissue, there 
was a moderate reduction in macrophages, and eosinophils in Batf2-/- mice in relation to WT 
mice during the infection (figure 17B). This data shows that the cell populations known to 
contribute to Schistosomiasis-induced inflammatory immune response (CD4+ T cells, 
macrophages, eosinophils) were decreased in the gut of Batf2-/- mice.  Conversely, the cells 
that have been reported to contribute to Schistosomiasis-induced immune regulation (CD8+ T 
cells) were increased in the small intestinal tissue of Batf2-/- mice in relation to WT mice during 
chronic S. mansoni infection (Pedras-Vasconcelos, 1996). Further analysis of the lymphocyte 
populations from the MLN revealed no significant differences in polarization for both CD4+ 
and CD8+ T cells in Batf2-/- mice in relation to WT mice (figure 17C, D). In terms of the 
effector function of these lymphocytes from MLN, the absence of Batf2 resulted in 
significantly reduced IL-4 and IL-5 producing CD4+ as well as CD8+ T cells (figure 17E, F). 
There was also a moderate reduction in the production of IL-13 by CD4+ T cells in Batf2-/- 
mice in relation to WT mice (figure 17E). These reduced immune effector populations 
suggested a reduced Th2 inflammatory immune response in the absence of Batf2 during 
chronic S. mansoni infection. On the other hand, there was also a moderate increase of IFN-γ 
producing CD8+ T cells in Batf2-/- mice in relation to the WT mice (figure 17F). Furthermore, 
the overall tissue specific cytokines including IFN-γ, TNF-α, IL-4, IL-5, IL-13 and IL-17 in 
the small intestinal tissue measured using ELISA (figure 17G, H), showed that the removal of 
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Batf2 results in significant reduction of IL-17 and moderate reduction of TGF-beta which might 
both contribute to the observed reduction in small intestinal inflammation during chronic 
schistosomiasis. Altogether, the data revealed that the absence of Batf2 contributes to reduced 
inflammatory immune response in the small intestinal tissue during chronic Schistosomiasis 
disease.    
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Figure 17: Removal of Batf2 results in reduced small intestinal inflammatory immune response during 
chronic S. mansoni infection. 
Batf2-/- and WT mice were percutaneously infected with a dose of 35 S. mansoni cercariae and the immune 
responses were analysed in the small intestinal tissue and mesenteric lymph nodes (MLN) during week 10 post 
infection. Quantification of MLN lymphocytes (A) and myeloid cellular populations in the small intestine (B) 
analysed using flow cytometry. Quantification of MLN CD4+ (C) and CD8+ (D) T lymphocyte polarization 
during the infection analysed using flow cytometry. Quantification of cytokine producing CD4+ (E) and CD8+ 
(F) T lymphocytes from MLN re-stimulated with PMA/Ionomycin and analysed on flow cytometry.  Small 
intestinal cytokine concentrations per gram of tissue measured using ELISA (G, H). Data represents two 
experiments conducted independently (n = 7-10). The comparisons of the bar graphs were performed using student 
t test. *p value < 0.05 and **p value < 0.01. 
 
4.2.4.3. Lung immune response in Batf2-/- mice during chronic S. mansoni infection. 
The absence of Batf2 results in reduced lung tissue cellular count which suggested a potentially 
reduced inflammation (figure 15). Although the immune profile of the lung revealed a 
moderate increase in the recruitment of CD8+ T cells as well as eosinophils (figure 18A), what 
was prominently affected in the tissue, which may have contributed to reduced tissue 
inflammation, were the significantly reduced recruitment of mature neutrophils in Batf2-/- mice 
in relation to the WT mice (figure 18B). Furthermore, the absence of Batf2 moderately 
increased polarization of the CD4+ T cells into Th2 subsets (figure 18C) while the CD8+ T 
cells were significantly more polarized into regulatory subset (figure 18D) in relation to the 
control WT mice. Even though the cytokine-producing CD4+ T cells were not significantly 
different (figure 18E), there was, however, a moderate increase in IL-4 producing CD8+ T cells 
(figure 18F) in the absence of Batf2. Collectively the data show a reduced lung neutrophilic 
inflammatory immune response that is linked with increased regulatory CD8+ T cells in the 
absence of Batf2 during chronic S. mansoni infection.   
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Figure 18: The absence of Batf2 results in reduced lung neutrophilic inflammation during chronic S. 
mansoni infection.  
Batf2-/- and WT mice were percutaneously infected with a dose of 35 S. mansoni cercariae and the immune 
responses in the lung tissue were analysed during week 10 post infection. Quantification of immune cellular 
populations in percentages analysed using flow cytometry (A, B). Percentage quantification of CD4+ (C) and 
CD8+ (D) T cell polarization measured using flow cytometry. Percentage quantification of cytokine producing 
CD4+ (E) and CD8+ (F) T lymphocytes re-stimulated with PMA/Ionomycin and analysed on flow cytometry. 
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Data represents two experiments conducted independently (n = 7-10). The comparisons of bar graphs were 
performed by student t test. *p value < 0.05 and **p value < 0.01.  
 
Of interest considering the reduced liver immunopathology, the recruitment of immune 
populations especially the CD19+ B cells and regulatory foxp3+ T cells were either reduced or 
not affected by the absence of Batf2, however, the effector CD8+ T cells (IFN-γ and IL-13 
producing CD8+ T cells) were significantly increased during the infection. This highlighted 
the potential of the CD8 T lymphocytes as key immune cell populations that may have 
contributed to the observed liver immunopathology in Batf2-/- mice during chronic S. mansoni 
infection.      
 
4.2.5. Injection of CD8 antibodies abrogates the prolonged survival and reduced tissue 
immunopathology of Batf2-/- mice during chronic S. mansoni infection.  
To address the significance of the CD8+ populations as key immune cell populations which 
contributed to liver granulomatous immunopathology in Batf2-/- mice during chronic S. 
mansoni infection, the mice were administered 200μg of α-CD8 antibodies orally to neutralize 
the population of CD8-expressing cells in Batf2-/- mice as previously demonstrated (Jung et 
al., 2018; Czuprynski and Brown, 1990; Adams et al., 1993). The α-CD8 treated Batf2-/- mice 
resulted in a significantly exacerbated liver granulomatous immunopathology in relation to the 
control untreated Batf2-/- mice during chronic schistosomiasis (figure 19A, B). There was also 
a moderate reduction in hepatic fibrosis in the liver tissue of α-CD8 treated Batf2-/- mice in 
relation to the control Batf2-/- mice (figure 19C, D). The data, therefore, show the CD8-
expressing immune populations play a significant role of regulating liver granulomatous 
immunopathology during chronic Schistosomiasis. Interestingly, failure of the CD8-expressing 
cells to regulate the immunopathology led to reduced survival of the α-CD8 treated Batf2-/- 
mice in relation to the Batf2-/- mice that did not receive α-CD8 during chronic S. mansoni 
infection (figure 19E), and this was not caused by differential worm burden (figure 19F). The 
study demonstrates a poorly understood vital role of CD8-expressing populations as one of the 
predominant cells that are required to regulate liver granulomatous immunopathology during 
chronic S. mansoni infection.    
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Figure 19: Administration of α-CD8 antibodies abrogates the prolonged survival and reduced tissue 
immunopathology of Batf2-/- mice during chronic S. mansoni infection. 
Batf2-/- and WT mice were infected percutaneously with a dose of 35 S. mansoni cercariae and were monitored 
up to 18 weeks post infection. Liver sections fixed in formalin were stained with H&E for morphological analysis 
of the egg-surrounding granuloma (200x) (A). Granuloma measurements quantified using microscopic analysis 
from H&E-stained sections (B). Liver sections fixed in formalin were stained with CAB staining for 
morphological analysis of fibrosis development in the liver of infected mice (200x) (C). Fibrosis measurements 
quantified using hydroxyproline assay on liver tissues (D). The survival of α-CD8 treated Batf2-/- mice was 
compared to that of Batf2-/- and WT mice during chronic S. mansoni infection (E). Quantification of S. mansoni 
eggs comparing the worm burden between WT, Batf2-/- and α-CD8 treated Batf2-/- mice during the infection (F). 
Comparison of survival curves were performed by Logrank test. The comparison of bar graphs was made using 
student t test. *p value < 0.05 and **p value < 0.01. (n = 7-12).  
 
4.3. Role of the intestinal microbiota of Batf2-/- mice during chronic S. mansoni 
infection.  
The commensal microbiota has been reported to be involved in a variety of physiological 
processes which include priming of the immune system to help maintain homeostasis and to 
protect from pathogens that invade the host (Wu, 2012; Turnbaugh, 2006). As demonstrated in 
figure 10, the removal of Batf2 results in altered intestinal microbiota, however, it was still 
unclear whether these changes do contribute to the observed pathogenesis of the mice during 
chronic Schistosomiasis. Considering the data presented so far, it was also possible that the 
observed changes in the immune system, especially the increased inflammatory mediators (IL-
17, IL4, IL5 and IFN-γ cytokines) in the liver were a result of the commensal microbiota during 
chronic S. mansoni infection. To address the role of the commensal microbiota of Batf2-/- mice 
during chronic Schistosomiasis, a co-housing model system was employed where the 
susceptible WT and the resistant Batf2-/- mice were placed in the same cage to allow the 
transfer of the commensal microbiota between the groups of mice prior and during the 
infection. This was a good model to follow given that mice are coprophagic and therefore, this 
allowed a continuous exchange of intestinal microbiota between the groups of mice throughout 
the infection (Stappenbeck and Virgin, 2016). Furthermore, some of the microbiota 
components such as enveloped virus, and anaerobic bacteria which may contribute to the 
phenotype, do not normally survive faecal transplantation procedure, and therefore, the co-
housing model allows for successful transfer of these microbes (Stappenbeck and Virgin, 2016)  
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Figure 20: Diagram illustrating the co-housing strategy used to allow the transfer of microbiota between 
WT and Batf2-/- mice during chronic S. mansoni infection.  
The WT and Batf2-/- mice were co-housed together 7 days prior to S. mansoni infection to allow gut microbial 
reprogramming within the mice. Using this model, four groups were generated i.e. (i) WT, (ii) Batf2-/-, (iii) WT 
Co-housed (WT-CH), (iv) Batf2-/- Co-housed (Batf2-/- CH).  
 
 
4.3.1. Intestinal microbiota transfer from Batf2-/- mice to wild type mice alters 
inflammatory immune responses in wild type mice during chronic S. mansoni infection. 
4.3.1.1. Alterations of hepatic immune responses in wild type mice recipient of Batf2-/- 
intestinal microbiota during chronic schistosomiasis.  
The study included four groups (WT, WT-CH, Batf2-/- and Batf2-/--CH) as depicted in figure 
20. The mice were percutaneously infected with a low dose of 35 S. mansoni cercariae to induce 
a chronic infection in the mice.  The immune profile associated with liver immunopathology 
following the microbial transfer was analysed. There was a significantly reduced recruitment 
of myeloid cells including total DCs, CD11b+ DCs, eosinophils and neutrophils in relation to 
the susceptible WT mice (figure 21A – D). Although, the recruitment of CD4+ T cells were 
not affected in the WT-CH mice in relation to the susceptible WT mice (figure 21E), their 
polarization into Th1 (T-bet) and Th2 (Gata3) subsets was significantly reduced during the 
infection (figure 21F - H). The recruitment of the CD8+ T cells together with their polarization 
into Th1 (T-bet) and Th2 (Gata3) subsets were not affected (figure 21I - K), however, their 
polarization into regulatory (Foxp3) subsets were significantly increased in the WT-CH mice 
in relation to the susceptible WT mice (figure 21L). In terms of the effector function of the T 
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lymphocytes, the IL-4, IL-5, and IL-13 producing CD4+ T cells were not affected in the WT-
CH mice in relation to the susceptible WT mice (figure 21M - O), however, the IFN-γ 
producing CD4+ T lymphocytes which were similar in WT mice in relation to Batf2-/- mice, 
were significantly increased in WT-CH and Batf2-/--CH mice indicating that this was an effect 
resulting from the alterations of intestinal microbiota of the mice during the infection  (figure 
21P). Unlike with the IFN-γ producing CD4 T lymphocytes, the IFN-γ producing CD8+ T 
lymphocytes in WT-CH mice were significantly increased in relation to the susceptible WT 
mice while that of the Batf2-/- mice were reduced (figure 21Q). Conversely, the production of 
IL-4 producing CD8+ T lymphocytes were significantly decreased in the WT-CH mice in 
relation to the susceptible WT mice, and those of the Batf2-/- -CH mice were significantly 
decreased in relation to Batf2-/- mice during the infection (figure 21R). The IL-5 producing 
CD8+ T lymphocytes were not affected by the transfer of intestinal microbiota in WT-CH 
mice (figure 21S), however the IL-13 producing CD8+ T lymphocytes were significantly 
increased in WT-CH mice in relation to those of susceptible WT mice (figure 21T). The data 
highlights a potential role of the microbiota of Batf2-/- mice in contributing to increased IFN-γ 
and IL-13 producing CD8 T lymphocytes and reduced CD8+ IL-4+ T lymphocytes during the 
chronic S. mansoni infection. Altogether, the intestinal microbiota of Batf2-/- mice induce 
alterations to Schistosomiasis-induced immune responses.    
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Figure 21: Co-housing results in alterations of hepatic immune responses in wild type mice recipient of 
Batf2-/- intestinal microbiota during chronic Schistosomiasis. 
Batf2-/-, WT, Batf2-/--CH, and WT-CH mice were percutaneously infected with a dose of 35 S. mansoni cercariae 
and the immune responses were analysed in the liver tissue during week 10 post infection. Quantification of 
myeloid populations including total DCs, CD11b Dc, eosinophils, and neutrophils analysed using flow cytometry 
(A – D).  Quantification of CD4+ T cells and polarization of the cell types in the liver analysed using flow 
cytometry (E – H). Quantification of CD8+ T cells and polarization of the cell types in the liver analysed using 
flow cytometry (I – L). Quantification of cytokine producing CD4+ T lymphocytes re-stimulated with 
PMA/Ionomycin and analysed on flow cytometry (M - P). Quantification of cytokine producing CD8+ T 
lymphocytes re-stimulated with PMA/Ionomycin and analysed on flow cytometry (Q - T). Data represents two 
experiments conducted independently (n = 7-10). The comparison of bar graphs was made using student t test. *p 
value < 0.05 and **p value < 0.01.  
 
Furthermore, the tissue specific cytokines of the liver tissue were also analysed using ELISA. 
The concentrations of the tissue cytokines, IL-10 and IFN-γ, were increased in the WT-CH 
mice in relation to those of susceptible WT mice, although the differences in IL-10 cytokine 
concentrations were not significant (figure 22A, B). Interestingly, the inflammatory cytokines, 
IL-5 and IL-17, which were also increased in the resistant Batf2-/- mice, were also increased 
following the microbial transfer in the WT-CH mice in relation to the susceptible WT mice 
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(figure 22C, D). However, the concentrations of IL-4, IL13, and TNF-α in WT-CH mice were 
not affected in relation to those of the WT mice during the chronic infection indicating that the 
microbiota had no significant influence on the production of these cytokines during the 
infection (figure 22E - G). Altogether, the data from tissue specific cytokine profile shows that 
the microbiota from Batf2-/- mice results in altered immune mediators such as IL-10, IL-5, 
IFN-γ, and IL-17 cytokines.  
 
 
Figure 22: Co-housing results in alterations of hepatic cytokine responses in wild type mice recipient of 
Batf2-/- intestinal microbiota during chronic Schistosomiasis.  
Quantification of liver cytokine concentrations per gram of tissue measured using ELISA (A - G). Data represents 
two experiments conducted independently (n = 7-10). The comparisons of bar graphs were performed by student 
t test. *p value < 0.05 and **p value < 0.01. 
 
4.3.1.2. Alterations of intestinal immune responses in wild type mice recipient of Batf2-/- gut 
microbiota during chronic schistosomiasis. 
In terms of the small intestine, the intestinal microbiota of Batf2-/- mice resulted in significantly 
reduced recruitment of CD4+ T cells in WT-CH mice in relation to the susceptible WT mice 
during the chronic S. mansoni infection (figure 23A). However, the recruitment of the CD8+ 
T cells in the WT-CH mice were not affected in relation to WT mice (figure 23B). In the case 
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of myeloid cell populations including the macrophages and eosinophils, there were no notable 
differences in the recruitment of these cell populations as result of intestinal microbiota of 
Batf2-/- mice with the eosinophils being increased even further (figure 23C, D). Further 
analysis showed a significant reduction in Th2 CD4+ and CD8+ T cells (figure 23E – L) as 
evidenced by the reduction in IL-4, IL-5, IL-13 producing CD4+ T cells (figure 23E - G) as 
well as the IL-4 and IL-5 producing CD8 T cells in the mesenteric lymph nodes of the WT-
CH mice in relation to the susceptible WT mice during chronic S. mansoni infection (figure 
23I, J). This therefore showed that the microbiota of Batf2-/- mice have a significant role of 
regulating the small intestinal Th2 granulomatous inflammation during the chronic infection. 
Additionally, the IFN-γ producing CD8+ T lymphocytes in the WT-CH mice were moderately 
increased in relation to the susceptible WT mice (figure 23L). Analysis of the small intestinal 
tissue-specific cytokine revealed a significantly reduced production of IL-17 and TGF-β 
cytokines in WT-CH mice in relation to the susceptible WT mice during the infection 
indicating the significant impact of the intestinal microbiota of Batf2-/- mice on these cytokines 
in the intestine (figure 23M, N). The overall data from the small intestinal tissue show that the 
microbiota of Batf2-/- mice potentially have a vital role in regulating granulomatous 
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Figure 23: Co-housing results in alterations of intestinal immune responses in wild type mice recipient of 
Batf2-/- intestinal microbiota during chronic Schistosomiasis.   
Quantification of MLN CD4+ (A) and CD8+ (B) T lymphocytes as well as macrophages (C) and eosinophil (D) 
populations in the small intestine analysed using flow cytometry. Quantification of cytokine producing CD4+ (E 
- H) and CD8+ (I - L) T lymphocytes from MLN re-stimulated with PMA/Ionomycin and analysed on flow 
cytometry.  Small intestinal cytokine concentrations per gram of tissue measured using ELISA (M, N). Data 
represents two experiments conducted independently (n = 7-10). The comparisons of bar graphs were performed 
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4.3.1.3. Alterations of lung immune responses in wild type mice recipient of Batf2-/- intestinal 
microbiota during chronic schistosomiasis.   
In the case of the immune profile in the lung, the intestinal microbiota of Batf2-/- mice resulted 
in significant reduction on the recruitment of mature neutrophils in the WT-CH mice in 
relation to the susceptible WT mice during the infection (figure 24A). These immune 
populations were also prominently reduced in the Batf2-/- mice in relation to the WT mice 
indicating a potential role of the commensal microbiota of the Batf2-/- mice in regulating the 
cells during the infection. On the other hand, the microbiota of Batf2-/- mice resulted in 
significantly increased recruitment of eosinophils in WT-CH mice in relation to the susceptible 
WT mice (figure 24B). Although, the recruitment of the CD4+ T cells was not affected (figure 
24C), their polarization into Th2 subsets were significantly increased in the WT-CH mice in 
relation to the susceptible WT mice (figure 24E). Together, these cell populations (Eosinophils 
and CD4+ gata3+ T cells) were indicative of increased type 2 inflammatory immune response 
in the WT-CH mice in relation to the susceptible WT mice during the chronic S. mansoni 
infection. Regarding the CD8+ T cells, their recruitment to the lung tissue was moderately 
reduced in the WT-CH mice in relation to the susceptible WT mice during the infection (figure 
24G). Despite this reduction, the IL-5 producing CD8+ T cells were significantly increased in 
the WT-CH mice in relation to the susceptible WT mice during the infection. The observed 
increase in IL-5 producing CD8+ T cells were potentially contributing to the increased 
recruitment of the eosinophils in the WT-CH mice reported in figure 24B. With the data 
presented so far, it is evident that the intestinal microbiota of Batf2-/- mice induce alterations 
to immune responses in the tissue organs that are normally affected by the infection indicating 
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Figure 24: Co-housing results in alterations of lung immune responses in wild type mice recipient of Batf2-
/- intestinal microbiota during chronic Schistosomiasis.  
Batf2-/-, WT, Batf2-/--CH, and WT-CH mice were percutaneously infected with a dose of 35 S. mansoni cercariae 
and the immune responses in the lung tissue were analysed during week 10 post infection. Quantification of 
percentage myeloid cells mature neutrophils (A) and eosinophils (B) analysed on flow cytometry. Percentage 
CD4+ T cells (C) and their polarization into Th1 (T-bet+), Th2 (Gata3+), as well as into regulatory (Foxp3+) 
subsets (D - F).  Percentage CD8+ T cells (G) and their polarization into Th1 (T-bet+), Th2 (Gata3+), as well as 
into regulatory (Foxp3+) subsets (H - J). Quantification of cytokine producing CD4+ T cells re-stimulated with 
PMA/Ionomycin and analysed on flow cytometry (K - N). Quantification of cytokine producing CD8+ T cells re-
stimulated with PMA/Ionomycin and analysed on flow cytometry (O - S). Data represents two experiments 
conducted independently (n = 7-10). The comparisons of bar graphs were performed by student t test. *p value < 
0.05 and **p value < 0.01.  
 
4.3.2. Transfer of the intestinal microbiota from Batf2-/- mice ameliorates the tissue 
immunopathology in wild type mice during chronic S. mansoni infection.  
4.3.2.1. Co-housing of wild type mice with Batf2-/- mice results in significantly reduced liver 
granulomatous immunopathology in wild type mice during chronic S. mansoni infection. 
The following objective was to explore whether the immune alterations induced by the 
microbiota of Batf2-/- mice would result in any changes to the tissue immunopathology of the 
infected WT-CH mice. In terms of the liver, the altered immune responses in the tissue together 
with the intestinal microbiota from Batf2-/- mice resulted in significantly reduced hepatic 
granulomatous immunopathology in the WT-CH mice in relation to the susceptible WT mice 
during the chronic S. mansoni infection (figure 25A, B). Furthermore, this was also associated 
with moderately increased hepatic fibrosis in the WT-CH mice (figure 25C, D). This, 
therefore, showed that the intestinal microbiota from Batf2-/- mice contributed to the observed 
reduction in liver immunopathology in both the Batf2-/- and the WT-CH mice during chronic 
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S. mansoni infection. Conversely, the pathogenesis of Batf2-/- and Batf2-/--CH mice were not 
affected, which indicated that the intestinal microbiota from the susceptible WT mice had no 




Figure 25: Co-housing of wild type mice with Batf2-/- mice results in significantly reduced liver 
granulomatous immunopathology in wild type mice during chronic S. mansoni infection.  
Liver sections fixed in formalin were stained with H&E for morphological analysis of the egg-surrounding 
granuloma (200x) (A). Granuloma measurements quantified using microscopic analysis from H&E-stained 
sections (B). Liver sections fixed in formalin were stained with CAB staining for morphological analysis of 
fibrosis development in the liver of infected mice (200x) (C). Fibrosis measurements quantified using 
 
60 | P a g e  
 
hydroxyproline assay on liver tissues (D). Comparisons of survival curves were performed by Logrank test. The 
comparisons of bar graphs were performed by student t test. *p value < 0.05 and **p value < 0.01. (n = 7-12). 
 
4.3.2.2. Cohousing of wild type mice with Batf2-/- mice results in increased small intestinal 
fibrosis in wild type mice during chronic S. mansoni infection. 
Further analysis on the small intestinal tissue of the WT-CH mice showed no significant 
differences in the tissue immunopathology in relation to the susceptible WT mice during the 
chronic S. mansoni infection (figure 26A, B). This indicated that the immune alterations caused 
by the microbiota of Batf2-/- mice had no major influence on the granulomatous 
immunopathology observed in the small intestinal tissue of the WT-CH mice. Despite this, the 
development of fibrosis was significantly increased in the WT-CH mice in relation to the 
susceptible WT mice showing that the microbiota of Batf2-/- mice do contribute to mechanisms 
of tissue repair during the infection (figure 26C, D). Altogether, the data show that the 
microbiota from Batf2-/-mice contributed a significant role of potentiating the release of 
fibrosis in the small intestinal tissue of mice during chronic S. mansoni infection.    
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Figure 26: The intestinal microbiota of Batf2-/- mice results in increased small intestinal fibrosis during 
chronic S. mansoni infection. 
Formalin-fixed in small intestinal sections stained with H&E for morphological analysis of the cellular recruitment 
around the trapped S. mansoni eggs (200x) (A). Quantification of small intestinal cell counts (B). Formalin fixed 
small intestinal sections stained with CAB staining for morphological analysis of fibrosis development in the 
small intestinal of infected mice (200x) (C). Fibrosis measurements quantified using hydroxyproline assay on 
liver tissues (D). Quantification of S. mansoni egg counts (F). Data represents two experiments conducted 
independently (n = 7-10). The comparisons of bar graphs were performed by student t test. *p value < 0.05 and 
**p value < 0.01. 
 
4.3.2.3. Co-housing of wild type mice with Batf2-/- mice results in reduced immunopathology 
of the spleen and lungs in wild type mice during chronic S. mansoni infection.  
Lastly, there were no significant differences in liver, lung, and heart indices, as well as the 
small intestinal lengths between the groups of mice (WT, WT-CH, Batf2-/- and Batf2-/--CH) 
during the infection (figure 27A - E). However, the WT-CH mice had significantly reduced 
splenomegaly in relation to the susceptible WT mice during the infection (figure 27E). 
Although the lung weight was not affected (figure 27B), the tissue cellular count was, however, 
significantly reduced in the WT-CH mice in relation to the susceptible WT mice indicating an 
overall reduction in lung inflammation during the infection (figure 27F). The data, therefore, 
demonstrate that the immune alterations caused by the microbiota of Batf2-/- mice were 
contributing to Schistosomiasis-induced immunopathology.   
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Figure 27: The intestinal microbiota of Batf2-/- mice results in reduced immunopathology of the spleen and 
lung in mice during chronic S. mansoni infection. 
WT, WT-CH, Batf2-/--CH and Batf2-/- mice were infected with a dose of 35 S. mansoni cercariae and analysed 
at week 10 post infection. Liver (A), lung (B), heart (C), and spleen (D) weight indices were measured during 
chronic S. mansoni infection. Quantification of intestinal length in centimetres (E). Quantification of lung tissue 
cellular count (F). Data represents two experiments conducted independently (n = 7-10). The comparisons of bar 
graphs were performed by student t test. *p value < 0.05 and **p value < 0.01. 
 
4.3.3. Transfer of the gut microbiota from Batf2-/- mice prolongs the survival of wild type 
mice during chronic S. mansoni infection. 
Given all the changes the intestinal microbiota of Batf2-/- mice induced on tissue-immune 
responses which lead to the control of the disease-induced immunopathology during chronic 
Schistosomiasis, it was still to be determined if all these changes would affect the susceptibility 
of the mice to the infection. To confirm this, the mice were percutaneously infected with a low 
of 35 S. mansoni cercariae to induce chronic infection and were monitored throughout until 
each mouse succumbed to the infection. Interestingly, the susceptibility of the WT-CH mice 
was significantly reduced in relation to the WT mice (figure 28A). This was a result of the 
Batf2-/- mice-intestinal microbiota and not due to differences in infection intensity (figure 28B, 
C). However, the microbiota from the susceptible WT-CH mice did not affect or reduce the 
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survival of Batf2-/--CH mice in relation to the Batf2-/- mice, and this further indicated that the 
microbiota of WT mice had no major influence on the pathogenesis and susceptibility of the 
mice during chronic Schistosomiasis and this was indicative of a unidirectional transfer of the 
causal intestinal microbiota during the infection (figure 28A). What has been demonstrated at 
this point is that the removal of Batf2 induces changes in the commensal microbiota which 
contributes to the increased resistance of the mice during chronic S. mansoni infection. 
Altogether, the data highlights the interrelationship that exist between the host factor (Batf2), 
and the commensal microbiota on the susceptibility of mice during chronic S. mansoni 
infection.   
 
Figure 28: The microbiota from Batf2-/- mice contribute to increased resistance of mice during chronic S. 
mansoni infection. 
The survival of WT, WT-CH, Batf2-/--CH and Batf2-/- mice during chronic S. mansoni infection were 
compared(A). Quantification of S. mansoni eggs comparing the worm burden in the small intestinal tissue (B) as 
well the liver (C) during the infection. Data represents two experiments conducted independently (n = 7-12). 
Comparison of survival curves was made using Logrank test. The comparisons of bar graphs were performed by 
















5. Part 2 of the results:  
 
The role of the intestinal microbiota in the regulation of 
immunopathology during chronic Schistosomiasis. 
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5.1. Exacerbated immunopathogenesis of C57BL/6 mice housed under SPF facility 
during chronic Schistosomiasis. 
Another interesting observation was made during a preliminary experiment that was performed 
prior to the current study, where C57BL/6 mice from Specific Pathogen Free 2 (SPF2) facility 
of the University of Cape Town, were used to explore and understand the influence of 
Praziquantel on Schistosomiasis-induced immunopathology (Nono et al., 2020). The mice 
were percutaneously infected with a low dose of 35 S. mansoni cercariae and were to be 
monitored as per AEC approved protocol 016/027 for more than 10 weeks before administering 
praziquantel to the infected mice. The mice responded well to the infection for the first 7 weeks 
with no observable signs of distress and displayed a stable weight gain as is normally expected 
with Schistosomiasis infected mice (Figure 29A). Unexpectedly, the infected mice rapidly 
became lethargic and severely started losing weight from week 7 post infection onwards. The 
mice prematurely succumbed to the infection at a rapid rate of 6 mice dying within 3 days 
during week 7 to week 8 post infection.  Surprisingly, the premature mortality of these mice 
was not a result of a technical error where a higher pathogenic dose of infecting S. mansoni 
cercariae was administered as evidenced by even a lower parasite infiltration in the liver tissue 
(figure 29B). Despite the low dose of infection, the mice still resulted in increased liver 
granulomatous immunopathology that was characteristic of the Schistosomiasis disease (figure 
29C) indicating that the reported mortality was mediated in response to the infection. These 
observations, therefore, warranted a more in-depth investigation to understand further the cause 
of early mortality.       
 
Figure 29: Confirmation of low-dose infection by assessment of body weight and liver immunopathology of 
C57BL/6 mice.  
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Liver egg burden from the Batf2 experiment taken from figure 12 that were infected with a low dose of 35 S. 
mansoni cercariae (Black and white filled bars) were compared to liver egg burden of C57BL/6 mice from a low 
dose infection of 35 S. mansoni cercariae per infection (Red bar). The bar graphs were compared using student t 
test. *p value < 0.05 and **p value < 0.01. 
 
It was hypothesised that the increased susceptibility of these SPF2 C57BL/6 mice (C57BL/6 
from SPF2) was potentially driven by their intestinal microbiota composition.  To test this, the 
SPF2 C57BL/6 mice were compared to C57BL/6 mice that were originating from another 
facility at the institute called the Specific Pathogen Free 1 (SPF1) facility. The comparison was 
made because of a previous demonstration that mice which originate from different 
environmental backgrounds result in commensal microbiota that are distinct from each other 
(Velazquez, 2019). The current study, therefore, aimed to extensively assess whether the 
observed susceptibility of the SPF2 C57BL/6 mice was different from that of the SPF1 
C57BL/6 mice and potentially report on the influence of microbiota to the susceptibility of 
these mice during chronic Schistosomiasis.  
 
5.2. Comparative survival of genetically identical mice housed in two different 
specific-pathogen-free facilities during chronic S. mansoni infection.   
5.2.1. Differential susceptibility of genetically identical mice housed under two different 
specific-pathogen-free facilities. 
The first objective was to test out if there were differences in susceptibility between the SPF1 
and SPF2 C57BL/6 mice during chronic S. mansoni infection, and for this the mice were 
percutaneously infected with a low dose of 35 S. mansoni cercariae. We noted that the SPF1 
C57BL/6 mice were more resistant to the chronic infection in relation to the SPF2 C57BL/6 
mice showing that there were differences which contributed to the susceptibility of C57Bl/6 
mice during chronic S. mansoni infection (Figure 30A). The differences in susceptibility were 
not caused by the trapped egg burden as there were similar liver egg counts between the mice 
(figure 30B).    
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Figure 30: Differential susceptibility of genetically identical mice housed under two different specific-
pathogen-free facilities.  
The survival of SPF1 C57BL/6 mice was compared to that of SPF2 C57BL/6 mice during chronic S. mansoni 
infection (A). Quantification of S. mansoni eggs comparing the worm burden between SPF1 and SPF2 C57BL/6 
mice during the infection (B). Data represents two experiments conducted independently (n = 7-12). Comparison 
of survival curves were performed by Logrank test. The comparisons of bar graphs were performed by student t 
test. *p value < 0.05 and **p value < 0.01. 
 
 
5.2.2. Increased granulomatous immunopathology around trapped eggs in tissues of 
susceptible mice (SPF2 C57BL/6) during chronic S. mansoni infection.  
5.2.2.1. Increased liver granulomatous response and reduced formation of fibrotic walls 
around trapped eggs in the liver of susceptible mice during chronic S. mansoni infection. 
The immunopathological features that were associated with the differences in susceptibility of 
the SPF1 and SPF2 C57BL/6 mice to chronic S. mansoni infection were explored. In terms of 
the liver pathology there was a significantly increased granulomatous immunopathology 
around the trapped S. mansoni eggs in the susceptible SPF2 C57BL/6 mice in relation to the 
resistant SPF1 C57BL/6 mice during the chronic infection (figure 31A, B). The observed 
increase in liver granulomatous immunopathology was associated with moderately reduced 
levels of hydroxyproline in the tissue (figure 31C, D). Altogether, the susceptibility of SPF2 
C57BL/6 mice was linked with significantly increased granulomatous immunopathology and 
reduced fibrosis in the liver tissue in relation to the resistant SPF1 C57BL/6 mice during the 
chronic S. mansoni infection.   
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Figure 31: Increased liver granulomatous response and reduced formation of fibrotic walls around trapped 
eggs in the liver of susceptible mice (SPF2 C57BL/6) during chronic S. mansoni infection. 
SPF1 and SPF2 C57BL/6 mice were infected percutaneously with a dose of 35 S. mansoni cercariae and analysed 
at week 10 post infection. Liver sections fixed in formalin were stained with H&E for morphological analysis of 
the egg-surrounding granuloma (200x) (A). Granuloma measurements quantified using microscopic analysis from 
H&E-stained sections (B). Liver sections fixed in formalin were stained with CAB staining for morphological 
analysis of fibrosis development in the liver of infected mice(200x) (C). Fibrosis measurements quantified using 
hydroxyproline assay on liver tissues (D). Data represents two experiments conducted independently (n = 7-10). 
The comparisons of bar graphs were performed by student t test. *p value < 0.05 and **p value < 0.01.  
 
5.2.2.2. Increased granulomatous responses around trapped eggs in the intestine of 
susceptible mice during chronic S. mansoni infection.   
Further analysis on immunopathology of the small intestinal tissue from the mice during the 
chronic S. mansoni infection revealed that the resistant SPF1 C57BL/6 mice had significantly 
reduced recruitment of cells surrounding the S. mansoni eggs (figure 32A) as well as intestinal 
cellular count (figure 32B) in relation to the susceptible SPF2 C57BL/6 mice. This indicated 
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a significantly reduced small intestinal inflammatory immunopathology of the resistant SPF1 
C57BL/6 mice in relation to the susceptible SPF2 C57BL/6 mice during the infection. 
However, there were no differences in the formation of fibrosis as evidenced by similar CAB 
staining (figure 32C) as well as hydroxyproline levels (figure 32D) in the small intestinal tissue 
of both SPF1 and SPF2 C57BL/6 mice. The effects observed in the small intestinal tissue were 
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Figure 32: Increased granulomatous responses around trapped eggs in 
the intestine of susceptible mice chronic S. mansoni infection. 
Small intestinal sections were formalin-fixed and stained with H&E for 
morphological analysis of the cellular recruitment around the trapped S. 
mansoni eggs (100x) (A). Quantification of small intestinal cell counts (B). 
Formalin fixed small intestinal sections stained with CAB staining for 
morphological analysis of fibrosis development in the small intestinal of 
infected mice (200x) (C). Fibrosis measurements quantified using 
hydroxyproline assay on liver tissues (D). Quantification of S. mansoni egg 
counts (E). Data represents two experiments conducted independently (n = 
7-10). The comparisons of bar graphs were performed by student t test. *p 
value < 0.05 and **p value < 0.01. 
 
 
5.2.2.3. Reduced lung weight index in susceptible mice during chronic S. mansoni infection. 
Further analysis revealed that there were no major differences observed in organ weight 
indexes such as the liver, heart, and spleen (figure 33A - C). Interestingly, the lung weight 
indexes of SPF2 C57BL/6 mice were significantly reduced in relation to that of SPF1 
C57BL/6 mice during the infection (figure 33D). However, despite this reduction, the lung 
cellular count was significantly increased in the susceptible SPF2 C57BL/6 mice in relation to 
the resistant SPF1 C57BL/6 mice (figure 33E). Considering all this, it can be concluded that 
the differences in susceptibility of the C57BL/6 mice from different SPF facilities are in part 
attributed to the lung immunopathology together with the liver and the small intestinal 
immunopathology during chronic Schistosomiasis.   
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Figure 33: Reduced lung index in susceptible mice during chronic S. mansoni infection. 
SPF1 C57BL/6 and SPF2 C57BL/6 mice were infected percutaneously with a dose of 35 S. mansoni cercariae 
and analysed at week 10 post infection. Liver (A), heart (B), spleen (C), and lung (D) weights were measured 
during chronic S. mansoni infection. Quantification of lung cellular count (E). Data represents two experiments 
conducted independently (n = 7-10). The comparisons of bar graphs were performed by student t test. *p value < 
0.05 and **p value < 0.01.  
 
5.2.3. Tissue immune alterations in response to chronic S mansoni infection of genetically 
identical mice housed under two different specific-pathogen-free facilities. 
5.2.3.1. Liver immune responses.     
The immune profiles that were associated with the immunopathology of the liver of both the 
SPF1 and SPF2 C57BL/6 mice were analysed (figure 34). Looking at the recruited T 
lymphocytes, there susceptible SPF2 C57BL/6 mice had significantly increased levels of 
CD8+ T cells in relation to those of the resistant SPF1 C57BL/6 mice during the chronic S. 
mansoni infection, and the populations of CD4+ T cells were not affected or different (figure 
34A). In the case of myeloid populations, the susceptible SPF2 C57BL/6 mice had 
significantly increased recruitment of eosinophils, while the recruitment of other myeloid cells 
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such as the neutrophils, total dendritic cells (DCs) as well as CD11b+ DCs, were significantly 
reduced in relation to those of the resistant SPF1 C57BL/6 mice (figure 34B). The data show 
that there was a dysregulated recruitment of protective immune populations forming the 
granuloma structure around the trapped S. mansoni eggs in the susceptible SPF2 C57BL/6 
mice in relation to the resistant SPF1 C57BL/6 mice during the infection. Additionally, even 
though the recruitment of the CD4+ T cells was not affected, their polarization into Th2 (gata3) 
subsets was significantly increased in the susceptible SPF2 C57BL/6 mice in relation to the 
resistant SPF1 C57BL/6 mice (figure 34C). Polarization of these cells into other subtypes such 
as Th1 (T-bet) and regulatory (foxp3) subsets were not affected (figure 34C). The CD8+ T cells 
on the other hand had significantly increased polarization of both Th1 (T-bet) and Th2 (gata3) 
subsets while the regulatory CD8+ T cells were not affected in the susceptible SPF2 C57BL/6 
mice in relation to those of the resistant SPF1 C57BL/6 mice (figure 34D). The effector 
functions of the CD4+ T cells were similar for both the susceptible SPF2 C57BL/6 and the 
resistant SPF1 C57BL/6 mice with the production of IFN-γ and IL-13 being moderately 
reduced (figure 34E). The CD8+ T cells producing IFN-γ were significantly reduced, while the 
IL-5 producing CD8+ T cell were only moderately reduced in the susceptible SPF2 C57BL/6 
mice (figure 34F). The IL-13 producing CD8+ T cells were increased in the susceptible SPF2 
C57BL/6 mice in relation to the resistant SPF1 C57BL/6 mice during the infection (figure 
34F).   
 
In terms of the tissue specific cytokines, the susceptible SPF2 C57BL/6 mice had moderately 
increased inflammatory cytokines such as TNF-α, IL-13, IL-17, and significantly increased 
TGF-β and IL-10 in the tissue in relation to those of the resistant SPF1 C57BL/6 mice (figure 
34G, H). Despite this, the tissue immune alterations resulted in increased liver 
immunopathology observed in the susceptible SPF2 C57BL/6 mice in relation to the resistant 
SPF1 C57BL/6 during chronic S. mansoni infection.  
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Figure 34: Altered hepatic immune responses in susceptible SPF2 C57BL/6 mice when compared to the 
resistant SPF1 C57BL/6 during chronic S. mansoni infection. 
SPF2 and SPF1 C57BL/6 mice were infected percutaneously with a dose of 35 S. mansoni cercariae and the 
immune responses were analysed in the liver tissue during week 10 post infection. Quantification of immune 
cellular populations analysed using flow cytometry (A, B). Quantification of CD4+ (C) and CD8+ (D) T 
lymphocyte polarization during the infection analysed using flow cytometry. Quantification of cytokine producing 
CD4+ (E) and CD8+ (F) T lymphocytes re-stimulated with PMA/Ionomycin and analysed on flow cytometry.  
Liver cytokine concentrations per gram of tissue measured using ELISA (G, H). Data represents two experiments 
conducted independently (n = 7-10). The comparisons of bar graphs were performed by student t test. *p value < 
0.05 and **p value < 0.01.  
 
5.2.3.2. Small intestinal immune response   
In terms of the immune profile that was associated with small intestinal immunopathology 
during chronic S. mansoni infection, there was a significantly increased recruitment of CD4+, 
CD8+ T cells in the mesenteric lymph nodes (figure 35A), and small intestinal macrophages, 
and eosinophils in the susceptible SPF2 C57BL/6 mice in relation to the resistant SPF1 
C57BL/6 mice during chronic S. mansoni infection (figure 35B). The polarization of both 
CD4+ and CD8+ T cell into Th1 (T-bet) and Th2 (gata3) subsets were significantly increased 
in these susceptible SPF2 C57BL/6 mice (figure 35C, D). There was also a significantly 
increased regulatory subsets (foxp3) of CD4+ T cells (figure 35C) in the susceptible SPF2 
C57BL/6 mice in relation to the resistant SPF1 C57BL/6 mice, while those of CD8+ T cells 
were similar (figure 35D). Although the susceptible SPF2 C57BL/6 mice had increased 
polarization of the T lymphocytes, their ability to release inflammatory cytokines (IL-4, IL-5, 
IL-13) were significantly reduced in both CD4+ and CD8+ T cells in relation to those of the 
resistant SPF1 C57BL/6 mice (figure 35E, F). However, the overall production of 
inflammatory cytokines (figure 35G, H) in the small intestinal tissue were not reduced between 
the mice during chronic S. mansoni infection. The levels of IL-4 cytokines were significantly 
reduced in the susceptible SPF2 C57BL/6 mice in relation to the resistant SPF1 C57BL/6 
mice (figure 35G). A type 1 inflammatory cytokine such as TNF-α was significantly increased 
(figure 35G) while the regulatory IL-10 (figure 35H) cytokine was moderately reduced in the 
tissue of the susceptible SPF2 C57BL/6 mice in relation to those of the resistant SPF1 
C57BL/6 mice during chronic S. mansoni infection. Altogether, the increased 
immunopathology observed in the small intestinal tissue of SPF2 C57BL/6 mice was a result 
of increased inflammatory immune response during the infection.   
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Figure 35: Altered small intestinal immune responses in susceptible SPF2 C57BL/6 mice when compared 
to the resistant SPF1 C57BL/6 during chronic S. mansoni infection. 
SPF1 and SPF2 C57BL/6 mice were infected percutaneously with a dose of 35 S. mansoni cercariae and the 
immune responses were analysed in the small intestinal tissue and mesenteric lymph nodes (MLN) during week 
10 post infection. Quantification of MLN lymphocytes (A) and myeloid cellular populations in the small intestine 
(B) analysed using flow cytometry. Quantification of MLN CD4+ (C) and CD8+ (D) T lymphocyte polarization 
during the infection analysed using flow cytometry. Quantification of cytokine producing CD4+ (E) and CD8+ 
(F) T lymphocytes from MLN re-stimulated with PMA/Ionomycin and analysed on flow cytometry.  Small 
intestinal cytokine concentrations per gram of tissue measured using ELISA (G, H). Data represents two 
experiments conducted independently (n = 7-10). The comparisons of bar graphs were performed by student t test. 
*p value < 0.05 and **p value < 0.01.  
 
5.2.3.3. Lung immune responses 
The immune profile that was associated with the lung immunopathology of the susceptible and 
resistant SPF1 and SPF2 C57Bl/6 mice respectively were analysed during the chronic S. 
mansoni infection. The increased lung cellular count in the susceptible SPF2 C57Bl/6 mice 
was linked with increased recruitment of CD8+ T populations, macrophages, immature and as 
well as mature neutrophils in the lung tissue during the infection (figure 36A, B). Further 
analysis on polarization of the lymphocytes revealed that the CD4+ T cells in the susceptible 
SPF2 C57Bl/6 mice was comparable to those of the resistant SPF1 C57Bl/6 mice during the 
infection (figure 36C). Conversely, the polarization of CD8+ T cells into Th1 (T-bet) and Th2 
(gata-3) subsets were significantly increased in the susceptible SPF2 C57Bl/6 mice in relation 
to resistant SPF1 C57Bl/6 mice (figure 36D). However, the regulatory subset of the CD8+ T 
cells in SPF2 C57Bl/6 mice were significantly reduced in relation to those of SPF1 C57B/6 
mice (figure 36D). In terms of the effector function of the T lymphocytes in the lung tissue, 
both CD4+ and CD8+ T cells had moderately increased IFN-γ, and reduced IL-13 producing 
T lymphocytes in the susceptible SPF2 C57Bl/6 mice in relation to the resistant SPF1 C57Bl/6 
mice during the infection (figure 36E, F). Furthermore, the IL-5 producing CD8+ T cells were 
moderately increased in the susceptible SPF2 C57Bl/6 mice in relation to the resistant SPF1 
C57Bl/6 mice during the infection (figure 36F). Although the effector function of the T 
lymphocytes was not highly affected, the recruitment of immune cells which contribute 
inflammatory immune responses were significantly increased in the susceptible SPF2 C57Bl/6 
mice in relation to the SPF2 C57Bl/6 mice during chronic S. mansoni infection. Therefore, the 
susceptibility of SPF2 C57Bl/6 mice was linked with increased lung inflammatory immune 
responses during chronic Schistosomiasis.     
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Figure 36: Altered lung immune responses in susceptible SPF2 C57BL/6 mice when compared to the 
resistant SPF1 C57BL/6 during chronic S. mansoni infection.  
SPF1 and SPF2 C57BL/6 mice were infected percutaneously with a dose of 35 S. mansoni cercariae and the 
immune responses in the lung tissue were analysed during week 10 post infection. Quantification of immune 
cellular populations analysed using flow cytometry (A, B). Quantification of CD4+ (C) and CD8+ (D) T cell 
polarization measured using flow cytometry. Quantification of cytokine producing CD4+ (E) and CD8+ (F) T 
lymphocytes re-stimulated with PMA/Ionomycin and analysed on flow cytometry. Data represents two 
experiments conducted independently (n = 7-10). The comparisons of bar graphs were performed by student t test. 
*p value < 0.05 and **p value < 0.01. 
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5.3. The role of the intestinal microbiota in the differential susceptibility of 
genetically identical mice housed under different specific-pathogen-free facilities 
during chronic S. mansoni infection. 
Given that the genetically identical resistant (SPF1 C57Bl/6) and susceptible (SPF2 C57Bl/6) 
mice were responding different to chronic Schistosomiasis and had altered immune responses 
which also affected the immunopathology, the study therefore, aimed to address and show the 
potential role of intestinal microbiota on the pathogenesis of these mice during the infection. 
The SPF1 and SPF2 C57Bl/6 mice were co-housed together to allow the transfer of intestinal 
microbiota between the resistant SPF1 C57Bl/6 and the susceptible SPF2 C57Bl/6 mice during 
chronic S. mansoni infection. The model resulted in four groups including the SP1, SP2, SP1-
CH (CH = Co-housing) and SP2-CH C57Bl/6 mice (figure 37). The mice were then 
percutaneously infected with a low dose of 35 S. mansoni cercariae to induce chronic 
Schistosomiasis.   
 
Figure 37: Diagram illustrating the co-housing strategy used to allow the transfer of microbiota between 
SPF1 and SPF2 C57BL/6 mice during chronic S. mansoni infection.  
The SPF1 and SPF2 C57BL/6 mice were co-housed together 7 days prior to S. mansoni infection to allow gut 
microbial reprogramming within the mice. Using this model, four groups were generated i.e. (i) SPF1 C57BL/6 
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5.3.1. Immune alterations as a result of intestinal microbiota transfer from genetically 
identical resistant to the susceptible mice during chronic S. mansoni infection 
The immune profile of the SP1, SP2, SP1-CH (CH = Co-housing) and SP2-CH C57Bl/6 mice 
were analysed in order to assess whether the intestinal microbiota do contribute to the altered 
immune responses during chronic Schistosomiasis. 
 
5.3.1.1. Alterations in liver immune responses following co-housing of genetically identical 
resistant and susceptible mice during chronic S. mansoni infection. 
The immune profile that was associated with the liver immunopathology of the SPF2-CH 
C57Bl/6 mice during chronic S. mansoni infection was explored. The susceptible SPF2 
C57Bl/6 mice were characterized by dysregulated recruitment of myeloid populations as 
evidenced by significantly increased recruitment of eosinophils, and significant reduction in 
dendritic cells as well as neutrophils in relation to the resistant SPF1 C57Bl/6 mice (figure 
38A - D). However, the recruitment of these myeloid populations was changed in the SPF2-
CH C57Bl/6 mice resulting in reduced recruitment of eosinophils, and significantly increased 
populations of total DCs, CD11b+ DCs, and moderate increase of the neutrophils which then 
resembled the profile of the resistant SPF1 C57Bl/6 mice during the infection (figure 38A - 
D).  
 
The recruitment of the CD4+ T cells was not different between groups (figure 38E). However, 
the CD4+ T cells in the susceptible SPF2 C57Bl/6 mice were significantly more polarized into 
Th2 (gata3) subsets and moderately more polarised into Th1 (T-bet) subsets in relation to the 
resistant SPF1 C57Bl/6 mice (figure 38F, G). The SPF2-CH C57Bl/6 mice still maintained 
the increased polarization of the CD4+ T cells into Th2 and Th1 subsets indicating that the 
microbiota from SPF1-CH C57Bl/6 mice did not affect these CD4+ T cell subsets during the 
chronic infection (figure 38F, G). Furthermore, polarization of the CD4+ T cells into regulatory 
subsets was not majorly affected between the susceptible SPF2 C57Bl/6 and the resistant SPF1 
C57Bl/6 mice, however the SPF2-CH C57Bl/6 mice resulted in moderately increased CD4+ 
T regulatory cells during the infection (figure 38H).  
 
In terms of the effector function of the CD4+ T cells, the data showed no significant influence 
on the IL-4 and IL-5 producing CD4+ T cells in either the resistant or the susceptible mice, but 
the SPF2-CH C57Bl/6 mice resulted in significantly increased IL-5 producing CD4+ T cells 
in relation to the susceptible SPF2 C57Bl/6 mice (figure 38I, J). There was also a moderate 
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increase in IFN-γ and IL-13 producing CD4+ T cells in the SPF2-CH C57Bl/6 mice in relation 
to the susceptible SPF2 C57Bl/6 mice during the infection (figure 38K, L).   
 
The recruitment of the CD8+ T cells were significantly increased in the susceptible SPF2 
C57Bl/6 mice in relation to the resistant SPF1 C57Bl/6 mice (figure 38M). Following the 
microbial transfer, these cells were then moderately reduced in the SPF2-CH C57Bl/6 mice in 
relation to the susceptible SPF2 C57Bl/6 mice (figure 38M). Although the polarization of the 
CD8+ T cells into Th1 (T-bet) and Th2 (Gata3) subsets were significantly increased in the 
susceptible SPF2 C57Bl/6 mice in relation to the resistant SPF1 C57Bl/6 mice, only the Th2 
CD8+ T cell subsets were moderately reduced in the SPF2-CH C57Bl/6 mice while the Th1 
CD8+ T cell subsets remained the same in relation to the susceptible SPF2 C57Bl/6 mice 
(figure 38N, O). This indicated that the microbiota from the resistant SPF1 C57Bl/6 mice were 
enough to reduce the inflammatory Th2 and increase anti-inflammatory Th1 responses 
mediated by the CD8+ T cells during chronic S. mansoni infection. Furthermore, the regulatory 
CD8+ T cells were also not significantly affected between the resistant SPF1, susceptible SPF2 
C57Bl/6 and the SPF2-CH C57Bl/6 mice during the infection (figure 38P).  
 
In terms of the effector function of the CD8+ T cells, the IL-4 producing CD8+ T cells were 
not affected (figure 38Q), however, other Th2 mediators were interchanged, where the IL-5 
producing CD8+ T cells were moderately increased while the IL-13 producing CD8+ T cells 
were moderately reduced in the SPF2-CH C57Bl/6 mice in relation to the susceptible SPF2 
C57Bl/6 mice during the infection (figure 38R, S). On other hand, the IFN-γ producing CD8+ 
T cells which were significantly low in the susceptible SPF2 C57Bl/6 mice in relation to the 
resistant SPF1 C57Bl/6 mice, were significantly increased in the SPF2-CH C57Bl/6 mice in 
relation to the susceptible SPF2 C57Bl/6 mice (figure 38T). Altogether, the data indicated that 
the commensal microbiota of the resistant SPF1 C57Bl/6 mice contributed altered immune 
responses which potentially may be contributing to the Schistosomiasis-induced liver 
immunopathology.  
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Figure 38: Altered liver immune responses following co-housing of genetically identical resistant and 
susceptible mice during chronic S. mansoni infection. 
SPF1-CH, SPF2, SPF1 and SPF2-CH C57Bl/6 mice were percutaneously infected with a dose of 35 S. mansoni 
cercariae and the immune responses were analysed in the liver tissue during week 10 post infection. Quantification 
of myeloid cellular populations analysed using flow cytometry (A - D). Quantification of liver CD4+ T cells (E) 
and their polarization (F - H) during the infection analysed using flow cytometry. Quantification of cytokine 
producing CD4+ T lymphocytes from liver tissue re-stimulated with PMA/Ionomycin and analysed on flow 
cytometry (I - L). Quantification of liver CD8+ T cells (M) and their polarization (N - P) during the infection 
analysed using flow cytometry. Quantification of cytokine producing CD4+ T lymphocytes from liver tissue re-
stimulated with PMA/Ionomycin and analysed on flow cytometry (Q - T). Data represents two experiments 
conducted independently (n = 7-10). The comparisons of bar graphs were performed by student t test. *p value < 
0.05 and **p value < 0.01.   
 
The liver tissue was analysed further and the concentrations of IL-4, IL-5 and IL-17 cytokines 
in the liver were found not to be significantly affected in the SPF2-CH C57Bl/6 mice in 
relation to the susceptible SPF2 C57Bl/6 mice during the chronic S. mansoni infection (figure 
39A - C). In terms of the concentrations of IL-13 and IFN-γ cytokines, their levels were similar 
between the susceptible SPF2 C57Bl/6 and the resistant SPF1 C57Bl/6 mice, and in both the 
mice following the microbial transfer, the concentration of these tissue cytokines were 
significantly increased indicating that the alteration in intestinal microbiota was the cause of 
 
83 | P a g e  
 
the observed increase of the two cytokines during the infection (figure 39D, E). On the other 
hand, the liver TNF-α levels which were increased in the susceptible SPF2 C57Bl/6 mice in 
relation to the resistant SPF1 C57Bl/6 mice, were reduced in the SPF2-CH C57Bl/6 mice in 
relation to the susceptible SPF2 C57Bl/6 mice during the infection and this indicated a 
reduction in type 1 inflammatory immune response in the SPF2-CH C57Bl/6 mice (figure 
39F). The transfer of the microbiota from SPF1-CH to SPF2-CH C57Bl/6 mice also resulted 
in significantly reduced levels of IL-10 and TGF-β in the SPF2-CH C57Bl/6 mice in relation 
to the susceptible SPF2 C57Bl/6 mice (figure 39G, H). The observed reduction in IL-10 and 
TGF-β was indicative of reduced type 2 and 17 immune regulatory mediators during the 
chronic S. mansoni infection.  
 
Figure 39: Altered liver cytokine responses following co-housing of genetically identical resistant and 
susceptible mice during chronic S. mansoni infection. 
Liver cytokine concentrations per gram of tissue measured using ELISA (A - H). Data represents two experiments 
conducted independently (n = 7-10). The comparisons of bar graphs were performed by student t test. *p value < 




84 | P a g e  
 
5.3.1.2. Alterations in intestinal immune responses following co-housing of genetically 
identical resistant and susceptible mice during chronic S. mansoni infection. 
The immune profile that was associated with the small intestinal tissue potentially driven by 
the microbiota from the SPF1-CH C57Bl/6 mice were analysed. Interestingly the susceptibility 
of the SPF2 C57Bl/6 mice was associated with significantly increased recruitment of CD4+, 
CD8+ T lymphocytes in MLN, as well as small intestinal macrophages, eosinophils, and 
neutrophils during the infection. The intestinal microbiota from SPF1-CH C57Bl/6 mice did 
not affect the recruitment of lymphocyte populations in MLN (figure 40A, B), they however, 
resulted in significantly reduced recruitment of the myeloid populations including the 
macrophages, eosinophils, and neutrophils in the SPF2-CH C57Bl/6 mice in relation to the 
susceptible SPF2 C57Bl/6 mice during the chronic infection (figure 40C - E).  
 
Although the recruitment of the lymphocytes remained higher, the polarization of both the 
CD4+ and CD8+ T cells into Th1 (T-bet), and Th2 (Gata3) subsets, including the regulatory 
CD4+ T subsets (Foxp3+ CD4+ T cells) were all significantly reduced in the SPF2-CH 
C57Bl/6 mice in relation to the susceptible SPF2 C57Bl/6 mice during the chronic S. mansoni 
infection (figure 40F - J). Interestingly, unlike the regulatory CD4+ T cells which were 
significantly reduced, the regulatory CD8+ T cells (CD8+ Foxp3+ T cells) were rather 
increased in the SPF2-CH C57Bl/6 mice in relation to the susceptible SPF2 C57Bl/6 mice 
(figure 40K).  
 
The effector functions of CD4 and CD8+ T cells were further analysed, and as already 
demonstrated, the susceptibility of the SPF2 C57Bl/6 mice was associated with significantly 
reduced production of IL-4, IL-5, and IL-13 by both the CD4+ and CD8+ T cells in relation to 
those of the resistant SPF1 C57Bl/6 mice during the infection while the while IFN-γ producing 
CD4+ and CD8+ T cells were the same (figure 40L - S). However, IFN-γ, IL-4, and IL-5 
producing CD4+ and CD8+ T cells of SPF2-CH C57Bl/6 mice were increased following the 
transfer of intestinal microbiota from SPF1 C57Bl/6 mice during the infection (figure 40M - 
R). Only the IL-13 producing CD4+ T cells were significantly increased while the IL-13 
producing CD8+ T cells were not affected in the SPF2-CH C57Bl/6 mice in relation to those 
of the susceptible SPF2 C57Bl/6 mice during chronic S. mansoni infection (figure 40O, S).  
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Figure 40: Altered small intestinal immune responses following co-housing of genetically identical resistant 
and susceptible mice during chronic S. mansoni infection. 
SPF1, SPF2, SPF1-CH and SPF2-CH C57Bl/6 mice were percutaneously infected with a dose of 35 S. mansoni 
cercariae and the immune responses were analysed in the small intestinal tissue and mesenteric lymph nodes 
(MLN) during week 10 post infection. Quantification of MLN CD4+ (A) and CD8+ (B) T lymphocytes, as well 
as small intestinal myeloid cellular populations (C - E) analysed using flow cytometry. Quantification of MLN 
CD4+ (F- H) and CD8+ (I - K) T lymphocyte polarization during the infection analysed using flow cytometry. 
Quantification of cytokine producing CD4+ (L - O) and CD8+ (P - S) T lymphocytes from MLN re-stimulated 
with PMA/Ionomycin and analysed on flow cytometry. Data represents two experiments conducted independently 
(n = 7-10). The comparisons of bar graphs were performed by student t test. *p value < 0.05 and **p value < 0.01.   
 
The small intestinal tissue was analysed further to explore the tissue cytokine responses 
associated with the observed altered immune responses during chronic S. mansoni infection. 
The production of IFN-γ, IL-13, TGF-β and IL-5 cytokines were comparable between the 
susceptible SPF2 C57Bl/6 and the SPF1, SPF1-CH and SPF2-CH C57Bl/6 mice during the 
chronic infection (figure 41A - E). Conversely, the level of IL-17 cytokines which contributes 
type 17 inflammatory response, were increased in both the SPF1-CH and SPF2-CH C57Bl/6 
mice (figure 41F). The levels of TNF-α which contributes to type 1 inflammatory immune 
response, were significantly reduced in the SPF2-CH C57Bl/6 mice in relation to the 
susceptible SPF2 C57Bl/6 mice during the infection (figure 41G).   
 
Interestingly, the levels of IL-4 cytokines were significantly increased in the SPF2-CH 
C57Bl/6 mice in relation to the susceptible SPF2 C57Bl/6 mice during the infection (figure 
41H). Given that IL-4 is a key cytokine that mediates a type 2 dependent immune response 
against the S. mansoni infection, the observed increase of this key cytokine was also linked 
with increased levels of regulatory IL-10 cytokine in the SPF2-CH C57Bl/6 mice in relation 
to the susceptible SPF2 C57Bl/6 mice (figure 41I). The data, therefore, meant that the 
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microbiota from SPF1-CH C57Bl/6 mice were responsible for the altered intestinal immune 
response during the infection.  
 
Figure 41: Altered small intestinal cytokine responses following co-housing of genetically identical resistant 
and susceptible mice during chronic S. mansoni infection. 
Small intestinal cytokine concentrations per gram of tissue measured using ELISA (A - I). Data represents two 
experiments conducted independently (n = 7-10). The comparisons of bar graphs were performed by student t test. 
*p value < 0.05 and **p value < 0.01.   
 
5.3.1.3. Alterations in lung immune responses following co-housing of genetically identical 
resistant and susceptible mice during chronic S. mansoni infection. 
The immune profile associated with the lung tissue revealed the tissue had significantly reduced 
recruitment of macrophages, immature and mature neutrophils in the SPF2-CH C57Bl/6 mice 
in relation to the susceptible SPF2 C57Bl/6 mice (figure 42A – C). Although the CD8+ T cells 
were moderately reduced in the SPF2-CH C57Bl/6 mice during the infection, their polarization 
into Th1 (T-bet) and regulatory (foxp3+) subsets were significantly increased while the Th2 
(Gata3) subsets were moderately reduced in relation to the susceptible SPF2 C57Bl/6 mice 
(figure 42D - G). In the case of the CD4+ T cells which were not majorly affected during the 
infection, their effector function was however affected following the microbial transfer. The 
IFN-γ and IL-13 producing CD4+ T cells which were increased in the susceptible SPF2 
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C57Bl/6 mice, were further potentiated in the SPF2-CH C57Bl/6 mice during the infection 
while the IL-5 producing CD4+ T cells remained the same (figure 42H - J). Similarly, the IFN-
γ and IL-13 producing CD8+ T cells were also potentiated further in the SPF2-CH C57Bl/6 
mice in relation to the susceptible SPF2 C57Bl/6 mice during the infection (figure 42K - M). 
Altogether, the data showed that the microbiota from SPF1-CH C57Bl/6 mice were able to 
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Figure 42: Altered lung immune responses following co-housing of genetically identical resistant and 
susceptible mice during chronic S. mansoni infection.  
SPF1, SPF2, SPF1-CH and SPF2-CH C57Bl/6 mice were percutaneously infected with a dose of 35 S. mansoni 
cercariae and the immune responses in the lung tissue were analysed during week 10 post infection. Quantification 
of immune cellular populations recruited to the tissue analysed using flow cytometry (A- D). Quantification of 
CD8+ T cell polarization measured using flow cytometry (E - G). Quantification of cytokine producing CD4+ (H 
- J) and CD8+ (K- M) T lymphocytes re-stimulated with PMA/Ionomycin and analysed on flow cytometry. Data 
represents two experiments conducted independently (n = 7-10). The comparisons of bar graphs were performed 
by student t test. *p value < 0.05 and **p value < 0.01.   
 
Interestingly, the immune responses of the affected tissues of the SPF1-CH C57Bl/6 mice were 
also altered following the microbial transfer, and this resulted in immune profile that resembled 
that of the susceptible SPF2 C57Bl/6 mice. This, therefore, demonstrated a bidirectional 
transfer of causal microbiota between the resistant SPF1 C57Bl/6 and susceptible SPF2 
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5.3.2. Transfer of the intestinal microbiota from resistant to susceptible mice result in 
ameliorated tissue immunopathology during chronic S. mansoni infection. 
5.3.2.1. The intestinal microbiota of resistant mice drives reduced hepatic immunopathology 
during chronic S. mansoni infection.  
Following the observed altered immune responses in the target tissues of SPF2-CH C57Bl/6 
mice driven by the intestinal microbiota, the immunopathological features associated with 
these changes were analysed to find out if the changes were enough to also alter the 
Schistosomiasis-induced immunopathology of infected mice. Analysis of the liver pathology 
showed that the immune responses in the SPF2 C57Bl/6 mice were associated with increased 
liver granulomatous immunopathology (figure 43A, B), which was then reversed or 
significantly reduced following the microbial transfer that altered the immune responses in 
liver of the SPF2-CH C57Bl/6 mice in relation to the susceptible SPF2 C57Bl/6 mice during 
the infection (figure 43A, B). However, the SPF1-CH C57Bl/6 mice also resulted in 
significantly increased liver granulomatous immunopathology the infection further confirming 
a bidirectional transfer of causal microbiota across the two groups of mice (figure 43A, B). 
Although the altered immune responses affected the development of granulomatous 
immunopathology around the trapped S. mansoni eggs, they however did not have a significant 
influence on the production of fibrosis as it remained higher in the liver tissue of the SPF2-CH 
C57Bl/6 mice and remained lower for the SPF1-CH C57Bl/6 mice during the infection (figure 
43C, D). The data, therefore, shows that the intestinal microbiota from SPF1-CH C57Bl/6 
mice alters the tissue immune response which in turn results in reduced liver granulomatous 
immunopathology while the microbiota from the SPF2-CH C57Bl/6 mice resulted in altered 
immune responses that causes exacerbated liver granulomatous immunopathology during 
chronic S. mansoni infection.   
 




Figure 43: The intestinal microbiota of resistant mice drives reduced hepatic immunopathology during 
chronic S. mansoni infection. 
Liver sections fixed in formalin were stained with H&E for morphological analysis of the egg-surrounding 
granuloma (200x) (A). Granuloma measurements quantified using microscopic analysis from H&E-stained 
sections (B). Liver sections fixed in formalin were stained with CAB staining for morphological analysis of 
fibrosis development in the liver of infected mice (200x) (C). Fibrosis measurements quantified using 
hydroxyproline assay on liver tissues (D). Comparison of survival curves was made using Logrank test. The 
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5.3.2.2. The intestinal microbiota of resistant mice drives increased small intestinal tissue 
immunopathology during chronic S. mansoni infection. 
The small intestinal tissue was then analysed to understand how the altered immune responses 
influenced tissue immunopathogenesis of the SPF2-CH C57Bl/6 mice during chronic S. 
mansoni infection. The susceptibility of SPF2 C57Bl/6 mice was linked with significantly 
increased small intestinal immunopathology in relation to the resistant SPF1 C57Bl/6 mice 
during the chronic S. mansoni infection (figure 44A, B). But the transfer of intestinal 
microbiota from the resistant SPF1-CH C57Bl/6 mice to the SPF2-CH C57Bl/6 mice which 
resulted in altered immune responses, did not influence, or result in reduced small intestinal 
immunopathology, however, the altered immune responses in SPF1-CH C57Bl/6 mice 
resulted in significantly increased intestinal immunopathology (figure 44A, B). Furthermore, 
both the SPF1-CH and the SPF2-CH C57Bl/6 mice resulted in similar levels of small 
intestinal fibrosis which were higher than the SPF1 and SPF2 C57BL/6 mice that were not co-
housed during chronic S. mansoni infection (figure 44C, D) indicating that the altered 
microbiota (dysbiosis) was responsible for the observed increase in the tissue fibrosis. To 
confirm the influence of the altered immune response on the tissue inflammation, the 
mesenteric lymph node (MLN) cells were also quantified. Interestingly, the MLN cell count of 
SPF2-CH C57Bl/6 mice was reduced in relation to the susceptible SPF2 C57Bl/6 mice during 
chronic S. mansoni infection (figure 44E). This, therefore, indicated that the altered immune 
responses in SPF2-CH C57BL/6 mice did influence a reduced intestinal immunopathology 
during chronic S. mansoni infection even though it was not strong enough to reverse the 
pathology.   
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Figure 44: The intestinal microbiota of resistant mice drives increased small intestinal immunopathology 
during chronic S. mansoni infection. 
Formalin-fixed small intestinal sections stained with H&E for morphological analysis of the cellular recruitment 
around the trapped S. mansoni eggs (100x) (A). Quantification of small intestinal cell counts (B). Formalin fixed 
small intestinal sections stained with CAB staining for morphological analysis of fibrosis development in the 
small intestinal of infected mice (200x) (C). Fibrosis measurements quantified using hydroxyproline assay on 
liver tissues (D). Quantification of MLN cell counts (E). Data represents two experiments conducted 
independently (n = 7-10). The comparisons of bar graphs were performed by student t test. *p value < 0.05 and 
**p value < 0.01. 
 
 
5.3.2.3. The intestinal microbiota of resistant mice drives increased lung weight that is 
associated with reduced cellular count during chronic S. mansoni infection.  
Further analysis on tissue immunopathology associated with chronic Schistosomiasis that were 
potentially affected by the intestinal microbiota revealed that there were no observable 
differences in the organ weight indices which included the liver, spleen as well as the heart 
(figure 45A – C). However, the lung index which was significantly reduced in the susceptible 
SPF2 C57Bl/6 mice in relation to the resistant SPF1 C57Bl/6 mice, was then increased in the 
SPF2-CH C57Bl/6 mice in relation to the susceptible SPF2 C57Bl/6 mice during the infection 
(figure 45D). Despite the increased lung index, the cellular count of the tissue in SPF2-CH 
C57Bl/6 was reduced in relation to the susceptible SPF2 C57Bl/6 mice indicating a reduction 
in inflammation during chronic Schistosomiasis (figure 45E). This, therefore, shows that the 
altered immune response in the lung contributed to reduced inflammation in the lung of SPF2-
CH C57Bl/6 mice during chronic Schistosomiasis.     
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Figure 45: The intestinal microbiota of resistant mice drives increased lung weight that is associated with 
reduced cellular count during chronic S. mansoni infection.  
SPF1, SPF2, SPF1-CH and SPF2-CH C57Bl/6 mice were percutaneously infected with a dose of 35 S. mansoni 
cercariae and analysed at week 10 post infection. Liver (A), heart (B), spleen (C), and lung (D) weights were 
measured during chronic S. mansoni infection. Quantification of MLN cellular count (E) were measured during 
chronic schistosomiasis. Data represents two experiments conducted independently (n = 7-10). The comparisons 
of bar graphs were performed by student t test. *p value < 0.05 and **p value < 0.01.  
 
Altogether, the data shows that the intestinal microbiota of SPF1-CH C57Bl/6 mice result in 
altered immune responses in target tissue (liver, small intestine, and lung) which in turn 
contribute to regulated immunopathology in infected C57Bl/6 mice.  
 
5.3.3. Transfer of the intestinal microbiota from resistant to susceptible mice result in 
prolonged survival of the susceptible mice during chronic S. mansoni infection.  
Considering the controlled immunopathology observed in SPF1 and SPF2-CH C57Bl/6 mice, 
and exacerbated immunopathology observed in SPF2 and SPF1-CH C57Bl/6 mice, the next 
objective was to explore how those changes translated in terms of the mice’ susceptibility 
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during chronic Schistosomiasis. Interestingly the controlled tissue immunopathology in SPF2-
CH C57BL/6 mice was enough to rescue the mice from premature mortality in relation to 
SPF2 C57Bl/6 mice (figure 46A: blue and white line graphs respectively), while the increased 
immunopathological changes observed in SPF1-CH C57Bl/6 mice resulted increased 
susceptibility of the mice in relation to the SPF1 C57Bl/6 mice during the infection (figure 
46A: grey and black line graphs respectively). The worm burden was similar across all the 
groups indicating that the observed differences in susceptibility were a result of the intestinal 
microbiota through priming of the immune responses that mediated Schistosomiasis-induced 
immunopathology in the mice (figure 46B and C). Given that both the SPF1-CH and SPF2-
CH C57Bl/6 mice’ susceptibility were affected during the infection, this therefore, 
demonstrates a bidirectional transfer of causal microbiota, with the intestinal microbiota of 
SPF1 C57Bl/6 mice driving a protective phenotype while the intestinal microbiota of SPF2 
C57Bl/6 mice drive a more pathogenic phenotype against chronic Schistosomiasis.   
 
Figure 46: Intestinal microbiota of resistant mice result in prolonged survival of the mice during chronic S. 
mansoni infection.  
The survival of SPF1, SPF1-CH, SPF2 and SPF1-CH C57BL/6 mice during chronic S. mansoni infection were 
compared(A). Quantification of S. mansoni eggs comparing the worm burden in the small intestinal tissue (B) as 
well the liver (C) during the infection. Data represents two experiments conducted independently (n = 7-10). 
Comparison of survival curves was made using Logrank test. The comparisons of bar graphs were performed by 
student t test. *p value < 0.05 and **p value < 0.01. 
 
5.3.4. Antibiotic treatment does not abrogate the protective potential of the intestinal 
microbiota of resistant mice.  
Given that the bacteria constitute a large number compared to other microbes in the intestine 
and have been shown to play crucial roles in diseases that are also caused by helminth infections 
(Rapin and Harris, 2018; Tlaskalová-Hogenová et al., 2011; Sender, R. et al. 2016), the next 
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step of the study was to confirm whether the observed changes in Schistosomiasis-induced 
pathogenesis was driven by the intestinal bacteria. For this, the SPF1 C57Bl/6 mice were orally 
administered with a broad-spectrum antibiotic (Abx) cocktail containing 0.8mg of Amoxicillin, 
1.7mg of Enrofloxacin, 0.2mg neomycin, and 0.2mg ampicillin dissolved in sterile water, for 
each SPF1 C57Bl/6 mouse to disrupt and reduce the number of bacterial populations. 
Following the treatment, these mice were then co-housed with the SPF2 C57Bl/6 mice to 
generate two new groups for the study. The antibiotic treated SPF1 C57Bl/6 mice were termed 
Abx+ SPF1-CH C57Bl/6 mice while the untreated SPF2 C57Bl/6 mice were termed Abx- 
SPF2-CH C57Bl/6 mice. The mice together with their controls (SPF1-CH and SPF2-CH 
C57Bl/6 mice) were percutaneously infected with a low dose of 35 S. mansoni cercariae to 
induce chronic Schistosomiasis. The antibiotic cocktail was administered every 3 days for the 
duration of the experiment. Over the course of infection, the antibiotic cocktail was 
demonstrated to be sufficient to significantly reduce both aerobic and anaerobic populations of 
bacteria in the Abx+ SPF1-CH C57Bl/6 mice (figure 47A - D: grey and blue bar graphs), 
while the levels of aerobic and anaerobic bacterial populations in Abx- SPF2-CH C57Bl/6 
mice remained unaffected throughout the infection (figure 47A - D: brown and red bar graphs). 
This experiment was performed to reprogram the intestinal microbiota so to disrupt the transfer 
of protective microbiota which would prevent the rescue of Abx- SPF2-CH C57Bl/6 mice 
during chronic Schistosomiasis. Surprisingly, this was not the case as the transfer of microbiota 
following the antibiotic treatment was still enough to rescue the Abx- SPF2-CH C57Bl/6 mice 
during the infection (figure 47E). This, therefore, demonstrated that the suspected bacteria were 









Figure 47: Antibiotic treatment does not abrogate the protective potential of the intestinal microbiota of 
resistant mice. 
Quantification of aerobic (A) and anaerobic (B) bacteria using TSA broth media during week 6 post S. mansoni 
infection. Quantification of aerobic (C) and anaerobic (D) bacteria using TSA broth media during week 12 post 
S. mansoni infection. The survival of SPF1-CH, SPF2-CH, Abx+ SPF1-CH and Abx- SPF1-CH C57BL/6 mice 
during chronic S. mansoni infection were compared (E). Data represents two experiments conducted 
independently (n = 7-10). Comparison of survival curves were performed by Logrank test. The comparisons of 
bar graphs were performed by student t test. *p value < 0.05 and **p value < 0.01.  
 
5.3.5. Comparative analysis of the intestinal microbiota profiles of the genetically 
identical susceptible and resistant mice 
Since it was still unclear which organisms were contributing to prolonged survival of the mice 
during chronic Schistosomiasis, the SPF1 and SPF2 C57BL/6 mice were screened to identify 
and compare intestinal microbes between these groups of mice. For this, serum and faecal 
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samples were collected from both the SPF1 and SPF2 C57BL/6 mice and were analysed using 
PCR, Indirect Immunofluorescence (IFA), and ELISA. The microbiological profiles were 
analysed by Biomedical Diagnostics (BioDoc, Germany) (Mr Jabu Magagula). According to 
the report that was provided the SPF2 C57BL/6 mice were found to be free of FELASA listed 
organisms including the Helicobacter sp, Murine norovirus (MNV) and Pasteurella 
pneumotropica, which are three organisms that were found to be present in the SPF1 C57BL/6 
mice that are more resistant to chronic Schistosomiasis (table 1). It can be suggested that one 
of these organisms if not all, were responsible for the prolonged survival of the SPF1 C57BL/6 
mice during the infection. Nevertheless, the study has therefore, extensively demonstrated the 
influence of intestinal microbiota on the pathogenesis of mice during chronic Schistosomiasis.   
 
Table 1: Screening of serum and faecal samples for detection and profiling of intestinal microorganisms 
in SPF1 and SPF2 C57BL/6 mice.  
  
  SPF1 C57BL/6   SPF2 
Microbe Method S1 S2 S3 S4   S1 S2 S3 S4 S5 
MHV IFA - - - -  - - - - - 
Reo3 IFA             
Theiler (GDVII) IFA - - - -  - - - - - 
PVM IFA - - - -  - - - - - 
Sendai IFA - - - -  - - - - - 
MVM IFA - - - -  - - - - - 
MPV IFA - - - -  - - - - - 
Ektromelie IFA - - - -  - - - - - 
LCMV IFA - - - -  - - - - - 
Adeno (MAd K87) IFA - - - -  - - - - - 
Polyoma IFA - - - -  - - - - - 
MTV IFA - - - -  - - - - - 
Hanta IFA - - - -  - - - - - 
MCMV IFA - - - -  - - - - - 
Rota (EDIM) IFA - - - -  - - - - - 
MNV IFA ++ +++ ++ +++   - - - - - 
LDV ELISA - - - -  - - - - - 
Mycopl. Pulmonis IFA - - - -  - - - - - 
Tyzzer (Cl. Piliforme) IFA - - - -  - - - - - 
Past. 
Pneumotropica IFA + + + +   - - - - - 
Toxoplasma gondiI IFA - - - -  - - - - - 
Encephalitozoon 
cun. IFA - - - -  - - - - - 
Helicobacter sp. PCR pos. pos. pos.     - - - - - 
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IFA Indirect Immunofluorescence     
ELISA enzyme-linked immunosorbent assay     
PCR Polymerase chain reaction     
S Sample     
            
+ weak reaction       
++ medium reaction       
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6. Discussions: 
The aim of the current study was to explore the interrelationship that exist between commensal 
microbiota, host genetic factor (Batf2), and the immune system to control disease 
complications such as chronic Schistosomiasis. And in so doing, the study has proved for the 
first time beyond association the presence of causal microbiota which contribute to the 
pathogenesis of S. mansoni infected mice leading to either increased or decreased susceptibility 
to the infection.  
 
6.1. Gene deletion and resistance to chronic Schistosomiasis 
The study initially explored the differential expression dynamics of Batf2 and its influence in 
mice if disrupted. Although removal of the transcription factor as previously demonstrated, 
does not induce any major physiological and immune cellular changes in the lung and liver 
tissues, it however has been demonstrated to alter immune cellular responses in small intestinal 
tissue of naïve mice (Guler et al 2018; Mpotje, 2017). The current study has demonstrated 
further that the removal of Batf2 alters the intestinal microbiota which potentially contributes 
to the altered immune responses even though the overall fitness of the mice was not affected 
during homeostasis. Considering all these, it stands to reason that the transcription factor has a 
direct link with the composition of the intestinal microbiota and thus help maintain 
homeostasis.   
Upon acute Schistosomiasis, the host maintains expression of Batf2 in small intestinal tissue 
and this helps regulate the type 2 and type 17 inflammatory responses mediated by both 
inflammatory T cells, which in turn also regulate the intestinal fibro-granulomatous 
immunopathology leading to prolonged survival of the infected mice (Guler et al, 2017). This, 
therefore, demonstrates that the Batf2 is an important regulator which allows for a well-
controlled type 2 and type 17 inflammatory immune responses in the intestine protecting the 
host against toxic pathogens, and in turn minimizes autoimmune-induced tissue damage during 
acute Schistosomiasis.  
Furthermore, the role of Batf2 is demonstrated to be tissue specific since it did not influence 
other tissue organs such as the liver despite the observed increase in expression during acute 
Schistosomiasis. Although the host still maintains increased expression of Batf2 in the liver 
during chronic Schistosomiasis, it was unclear how that translated into the tissue 
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immunopathology and ultimately the survival of the mice. Intriguingly, unlike with acute 
schistosomiasis, the absence of Batf2 during the chronic Schistosomiasis resulted in 
significantly prolonged survival of the mice.  
6.2. Immunity, immunopathology, and resistance to chronic Schistosomiasis 
Previous studies have demonstrated that the core of the pathology during schistosomiasis is 
primarily driven by excessive or unregulated inflammatory immune response to eggs rather 
than the cytotoxic action of the eggs themselves (Hams et al., 2013). Therefore, given that the 
removal of Batf2 in this current study resulted in significantly reduced type 2 inflammatory 
immune response (Figure 16), this might explain the reduced pathology observed in batf2-/- 
mice when compared to the WT mice despite similar levels of parasite egg loads. Additionally, 
the immunopathology of other tissue organs that are normally affected by the infection such as 
the lung, the small intestine, and the spleen, were also regulated.  
Interestingly, the reduced immunopathology was associated with increased tissue fibrosis 
which is known to be a wound healing factor that helps restore damaged tissue following an 
injury from autoimmune responses, mechanical stress, or infection (Kamden et al., 2018). 
However, S. mansoni infection causes an immune response that induces exacerbated liver 
fibrosis which in turn becomes pathogenic to the infected host (Kamdem et al., 2018; Andrade, 
2009; Hams et al., 2013). In the current study, we observed an increase in fibrosis in the 
resistant Batf2-/- mice which was also associated with reduced granulomatous pathology 
highlighting the potential need for increased fibrosis during chronic Schistosomiasis. It is not 
fully clear how this increase in fibrosis would affect the long-term tissue function. So far, the 
study further highlights the significance of finding an appropriate balance in the levels of 
fibrosis which would enable adequate wound healing ability while also being sufficient to keep 
the tissue integrity to prevent long term loss of tissue function. Importantly, as of yet, mice 
prone to develop such an elevated fibrosis in the midst of reduced granulomatous response 
tended to survive longer arguing in favour of the protective advantage of the pathophysiological 
display (elevated fibrosis + low granulomatous inflammation) during chronic schistosomiasis.   
Furthermore, there was also a reduction in inflammatory immune cell mediators such as 
inflammatory myeloid populations (neutrophils, eosinophils, and dendritic cells) as well as 
reduced type 2 adaptive T lymphocytes in the absence of Batf2. Additionally, the regulatory 
IL-10 also contributed to the observed immunopathology given that it was increased in the 
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knockout mice. Despite this immune profile, it was not surprising to see an increase in 
inflammatory IL-17 cytokine response in the liver of Batf2 deficient mice during the infection. 
This is because the transcription factor was previously reported to be an important inhibitor of 
immunopathological Th17 responses during helminth infection, Trypanosoma cruzi (Kitada, 
2017). However, this increase in inflammatory hepatic IL-17 and other inflammatory cytokines 
such as IFN-γ, IL-4, and IL-5 which were increased in the tissue, did not have major observable 
influence on the tissue immunopathology. Contrary to the liver, the IL-17 response was 
significantly reduced in the small intestine which contributed to reduced immunopathology. 
The differences in IL-17 responses between the liver and the small intestine suggest differential 
tissue specific role for Batf2.  
Furthermore, the lung immunopathology in the resistant Batf2 deficient mice was mainly 
attributed to significantly reduced recruitment of neutrophil populations given that the type 2 
immune response was not significantly affected, or rather was moderately increased suggesting 
a different regulatory role in the tissue compared to other target tissues such as the liver, the 
small intestine, and the spleen that were mainly influenced by reduced type 2 immune 
responses in the absence of Batf2. The findings from the current study revealed tissue-specific 
cytokine patterns as well as immune infiltrate in the lung vs liver, vs small intestine. This 
demonstrate differences in regulation of the host-pathogen interaction for each tissue type 
which can be attributed to differences in tissue cellular and molecular mechanisms, as well as 
tissue specific microbiota composition which are all capable of modulating host immune 
responses (Pestka et al., 2004; Wu et al., 2012; Turnbaugh et al., 2006). Based on the findings 
from the current study and by Guler et al. 2019, there appears to be a differential need for Batf2 
in the liver, lung and small intestine depending on the disease context. In the previous study, it 
was demonstrated that Batf2 did not have any observable influence in the lung and liver, while 
it was shown to be crucial in regulating against exacerbated intestinal inflammation during 
acute Schistosomiasis (Guler et al., 2019; Mpotje, 2017). This was also shown in a study by 
Kayama et al., (2019) where they demonstrated Batf2 to be crucial in preventing T cell 
mediated inflammation in the intestine through regulation of the IL-23/IL-17 pathway (Kayama 
et al., 2019).  
In the current study, there is a significant reduction in intestinal IL-17 mediated inflammation 
in the protected mice of Batf2 model (Batf2-/-, WT-CH, and Batf2-/- CH) during chronic 
Schistosomiasis. This indicates that the control of inflammation in the intestine is mediated 
mainly through the suppression of IL-17 mediated signaling that is independent of Batf2. 
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Therefore, Batf2-/--induce microbiota helps keep in check IL-17 mediated responses in the 
intestine during infection. In the case of other organs such as the liver, regulation of 
inflammatory immune responses by the absence of Batf2 during chronic Schistosomiasis, 
appears to be mediated through type 1 CD8+ T cell signaling and reduced recruitment of 
myeloid populations which led to reduced Th2 inflammatory immune response that was 
independent of IL-17 signaling (Figure 21 and 22). This can be attributed to the different 
composition of microbiota that the liver harbors which are not sufficient to induce exacerbated 
IL-17 responses. 
Overall, the observed reduction in inflammatory immunopathology of the Batf2 deficient mice 
suggested a different role for the Batf2 that is detrimental to the mice during chronic 
Schistosomiasis unlike its previously reported protective role during acute Schistosomiasis 
(Guler et al, 2017). The findings from this study regarding the hepatic immunopathology 
observed in the Batf2 deficient mice, are like those in a previous study by Layland et al. (2005) 
where they also showed that the absence of MyD88 in mice during Schistosomiasis results in 
reduced hepatic granulomatous inflammation that is associated with increased fibrosis in the 
tissue. However, the immunopathology was reported to be associated with a Th2 dominated 
phenotype as well as reduced percentages of eosinophils (Layland et al., 2005). Among the 
Th2 dominant phenotype were the T regulatory subsets (IL-10 producing T cells), which they 
reported to be responsible for the lack of antigen specific Th1 responses such as the IFN-γ 
producing T cells (Layland et al., 2005). Suppression of the Th1 responses were further 
reported to contribute to reduced liver immunopathology (Rezende et al., 1997; Layland et al., 
2005). 
Although it may be true that the lack of Th1 responses do contribute to reduced 
immunopathology, the current study however, point towards a more complicated role for the 
type 1 responses during chronic Schistosomiasis. This is because the absence of Batf2 did not 
affect the Th1 (IFN-γ producing CD4+ T cells) response, but rather resulted in increased type 
1 responses such as IFN-γ producing CD8+ T cells as well as overall tissue-specific cytokine, 
IFN-γ. Given that other reported regulatory mediators such as CD4+ foxp3+ T cells and the 
CD19 B cells (Hogan, 2002; Jankovic, 1998) were not affected or rather reduced in the absence 
of Batf2, it was therefore suggested that the reduced immunopathology in the absence of Batf2 
was also driven by the increase in type 1 responses especially those driven by the CD8+ T cells 
in the liver. This hypothesis is further supported by Pedras-Vasconcelos et al., (1996) and 
Pancreâ et al., (1999) where they demonstrated that the type 1 CD8+ T cells were contributing 
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to regulated liver granulomatous immunopathology during S. mansoni infection. Drawing from 
these observations, it was hypothesised that the role of type 1 responses on tissue 
immunopathology was either inflammatory or anti-inflammatory, and this was dependent on 
specific T cell subset. As shown in the study by Hernandez et al., (1998), the inflammatory 
Th1 response was driven by the CD4+ T lymphocytes. Even though Hoffmann et al., (2000) 
and Layland et al., (2005) only demonstrated the effect to be induced by total T lymphocytes. 
It was not well understood how the CD8+ T lymphocytes were contributing to the 
immunopathology in these studies. On the other hand, the type 1 responses mediated by IFN-
γ+ CD8+ T lymphocytes have also been reported to drive regulation of liver immunopathology 
(Pedras-Vasconcelos et al., 1996; Pancreâ et al., 1999). Given that the role of the CD8+ T cells 
is still poorly understood in the context of S. mansoni infection, the current study, therefore 
suggests a crucial role of the CD8+ T cells in regulating the liver granulomatous 
immunopathology in the absence of Batf2 during chronic S. mansoni infection. 
To confirm the suggested regulatory role of the CD8+ T cells, soluble anti-CD8 antibodies 
were used to neutralize the CD8+ expressing cells in Batf2 deficient mice during chronic S. 
mansoni infection. Interestingly, neutralization of the CD8+ expressing cells in the absence of 
Batf2, led to exacerbated hepatic granulomatous inflammation as well as premature mortality 
during chronic Schistosomiasis. This was consistent with what was reported in a study by 
Chensue et al., (1993). Since both, the T cell and dendritic cell populations can express the 
CD8 marker, it therefore, stands to reason that treatment with anti-CD8 antibody results in 
neutralization of both the CD8 expressing T lymphocytes as well as the CD8 expressing 
dendritic cells making it difficult to assess whether the CD8 T lymphocytes were responsible 
for the observed immunopathology. However, the CD8+ dendritic cells, which have a direct 
link with Batf2 during infections (Tussiwand et al., 2012), have been reported to play a 
significant role of cross priming with the CD8+ T cells through MHCI molecule, therefore 
highlighting a direct link between the cells (Fu and Jiang, 2018; Schnorrer et al, 2006). 
Altogether, the data demonstrates a poorly understood role of the CD8+ T cells, potentially 
through the CD8+ dendritic cells, in regulating chronic Schistosomiasis-induced 
immunopathology. Since the type 1 CD8+ T cells were more prominent in the resistant mice 
(Batf2 deficient mice) that were not treated with anti-CD8 antibodies during the infection, it 
can be suggested that these are the key immune cells driving improved protection of the Batf2 
deficient mice during chronic schistosomiasis.  
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Furthermore, previous studies have also demonstrated that schistosome egg antigens (SEA) are 
able to induce a type 1 CD8+ T cell response that plays a significant immunoregulatory role 
leading to a dampened immunopathologic type 2 responses and ultimately reduced 
granulomatous inflammation (Pancré et al., 1999, Pedras-Vasconcelo et al., 1996) as evidenced 
also in the current study. These studies suggested a potential use of schistosomiasis-induced 
type 1 CD8+ T cells as potential targets for immunization against the Schistosomiasis (Pancré 
et al., 1999). However, it was not clear whether the CD8+ T cell response was SEA specific or 
was a result of other potential antigens such as microbiota that may have led to the priming of 
the response during the infection. This was interesting since the absence of Batf2 was already 
shown to alter the composition of the intestinal microbiota. Additionally, the CD8+ T cells 
were more prominent in the Batf2 deficient mice suggesting that the response was potentially 
not SEA specific, but rather Batf2 mediated. This, therefore, meant that the absence of Batf2 
resulted in altered microbiota with the potential to prime for CD8+ T cell responses during the 
infection. 
Although the study shows that the CD8+ T cells do contribute to prolonged survival of Batf2-
/- mice; however, the prolonged survival can also be a result of CD4+ T cells which in the 
absence of Batf2, their inflammatory response was significantly reduced as demonstrated in 
Figure 16C and D. Furthermore, the reduced pathology was also a result of reduced recruitment 
of myeloid cells i.e.  neutrophils, eosinophils, and dendritic cells (Figure 16B) which contribute 
to formation of granulomatous inflammation during schistosomiasis (Hams et al., 2013) 
According to recent studies, it appears that Batf2 drives regulation T cell recruitment during 
inflammation through the activity of myeloid populations such as macrophages and dendritic 
cells (Kitada et al., 2017; Kayama et al., 2019). This was demonstrated by the studies where 
Batf2 inhibited expression of IL-23 in both macrophages and DCs which led to reduced Th17 
responses during T. cruzi infection (Kitada et la., 2017) and in a colitis model (Kayama et al., 
2019). In our previous work, we demonstrated the role of Batf2 to be crucial in differentially 
regulating inflammatory immune responses depending on the disease context (Guler et al., 
2019). The study demonstrated the transcription factor to be crucial in regulating against 
exacerbated type 2 inflammation that was associated with reduced recruitment of inflammatory 
T cells during acute Schistosomiasis (Guler et al., 2019). However, in the current study, I have 
demonstrated an alternative role of Batf2 in driving increased type 2 inflammation that is 
associated with increased recruitment of myeloid and T cells during chronic Schistosomiasis. 
The differences in recruitment of T cells during acute and chronic Schistosomiasis can be 
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attributed to altered Dendritic cell (DC) populations between the two phases of infection. This 
is because, during acute Schistosomiasis, there was an increase in DC populations in the 
absence of Batf2 which was also associated with increased T cell recruitment (Guler et al., 
2019), while during chronic Schistosomiasis, I observed a reduction in DC populations which 
was associated with reduced recruitment of T cells. 
6.3. Microbiota and resistance to chronic Schistosomiasis 
To address the role of the commensal microbiota on the pathogenesis of mice in the absence 
of Batf2 during chronic Schistosomiasis, the susceptible WT and resistant Batf2 deficient mice 
were co-housed together and were percutaneously infected with a low dose of 35 S. mansoni 
cercariae to induce chronic Schistosomiasis.   
Following the microbial transfer through co-housing, the Wildtype Co-housed (WT-CH) mice 
became more resistant to the infection while the Batf2 deficient Cohoused (Batf2-/--CH) mice 
were not majorly affected by the microbiota suggesting a unidirectional transfer of the causal 
microbiota. The increased resistance of the WT-CH mice was also associated with 
significantly reduced tissue immunopathology of the target tissues (spleen, liver, small 
intestine, and the lung), as well as increased fibrosis. The WT-CH mice resulted in 
immunopathogenesis that resembled that of the resistant Batf2 deficient mice during the 
chronic infection. These results, therefore, prove that the commensal microbiota from Batf2 
deficient mice were contributing to the reduced susceptibility of the mice during chronic 
Schistosomiasis.  
Furthermore, the prolonged survival was associated with reduced tissue immunopathology 
which was mediated by reduced type 2 inflammatory immune response driven by both myeloid 
and T lymphocytes in the major target tissues which include the liver and the small intestine. 
It is not clear what would happen in Batf2-/- mice treated with antibiotic or germ-free mice. 
This is because antibiotic treatment is diverse in its composition and scope of activity. The use 
of the presently reported cocktail might result in a similar phenotype for Batf2-/- mice than that 
of antibiotic treated SPF1 C57BL/6 mice, provided the protective microbe (s) is the same in 
both systems. This does not rule out a possible effect from our antibiotic treatment on this 
Batf2-/- system which would uncover another protective microbiota disposition than that of 
SPF1 C57BL/6 mice. Whatever the case, empirical assessment of the outcome of antibiotic 
treatment of Batf2-/- mice would be informative and is warranted.  
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The current study has demonstrated that Batf2-/--induced microbiota are responsible for driving 
reduced survival of the mice through exacerbated inflammatory immune responses during 
chronic Schistosomiasis. Furthermore, the data revealed that the intestinal microbiota from 
Batf2 deficient mice is responsible for the reduction in liver immunopathology, through the 
type 1 CD8+ T cells (IFN-γ producing CD8+ T cells). However, the exact mechanism of 
protection by the Batf2-induced microbiota has not been explored. The hypothesis from the 
observed current data and that from Kayamaya et al, (2019) is that the Batf2-induced 
microbiota lack factors/microbes that can recognize antigen presenting cells (APC) such as the 
CD8+ dendritic cells, which through MHCI molecules would activate the CD8+ T cells leading 
to expansion of protective type 1 CD8+ T cells during chronic Schistosomiasis (Wieczorek et 
al., 2017). 
It is not clear what the mechanism of reduced accumulation of immune cells in the liver of 
Batf2-/- mice is, however, it can be hypothesized that it is through priming of immune cells by 
the intestinal microbiota that is influenced by Batf2. This is based on the observation in my 
thesis that removal of Batf2 resulted in altered intestinal microbiota. Moreover, I also reported 
a reduced accumulation of immune cells in the livers of WT that had intact Batf2, following 
acquisition of microbiota from Batf2-/- mice.  
Interestingly, the microbiotas have a selective impact on the immune response during chronic 
Schistosomiasis having more effect on some cytokines such as IL-5, IL-10, IL-17, and IFN-γ, 
but no observable effect on IL-4 cytokine. This could be attributed to the fact that most of the 
mentioned cytokines (IL-5, IL-10, IL-17, and IFN-γ) are mainly T cell-mediated during 
Schistosomiasis (Yoshimoto, 2018, Hams et al., 2013; Pearce, 2002), while IL-4 is unique in 
that it plays a central role of priming naïve CD4+ T cells into Th2 phenotype that is required 
during Schistosomiasis, and the cytokine is primarily produced by eosinophils and basophils 
(Tang et al., 2018; Yoshimoto, 2018, Pearce, 2002). The Batf2-/- protective microbiotas are, 
therefore, hypothesized to regulate the T cell mediated responses, hence the IL-4 was not 
majorly affected during chronic Schistosomiasis. This is a very crucial finding given that IL-4 
deficient mice were observed to have impaired granuloma formation and developed acute fatal 
cachexia (Brunet et al., 1997; Pearce, 2002). The findings provide an IL-4 independent 
regulation of granulomatous inflammation which potentially prevents impaired granuloma 
formation and development of acute fatal cachexia during Schistosomiasis and thus providing 
a potential target for the development of a host-directed therapy during the disease (Brunet et 
al., 1997). 
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The influence of commensal microbiota on Schistosomiasis-induced pathogenesis was further 
demonstrated using C57BL/6 mice that were housed from two different facilities. This came 
about following an observation that the mice which were housed in Specific Pathogen Free 2 
(SPF2) facility were, surprisingly more susceptible to chronic Schistosomiasis even with a low 
dose of infection. This observation was further demonstrated when the susceptibility of these 
mice was then compared to that of genetically similar C57BL/6 mice that were housed in 
Specific Pathogen Free 1 (SPF1) facility. The SPF1 C57BL/6 mice were more resistant to the 
infection in relation to the SPF2 C57BL/6 mice. Furthermore, the susceptibility of the SPF2 
C57BL/6 mice was associated with increased tissue immunopathology in the liver, the small 
intestine as well as the lung, which were all driven by altered immune responses that favoured 
increased inflammation and hepatic eosinophilia during chronic Schistosomiasis. This, 
therefore, indicated that the mice coming from SPF2 facility were more susceptible to the 
infection in relation to the mice from SPF1 facility.   
To confirm whether the commensal microbiota was responsible for compromising the 
resistance of the SPF2 C57BL/6 mice during chronic Schistosomiasis, the susceptible SPF2 
C57BL/6 and resistant SPF1 C57BL/6 mice were co-housed together. This was done to 
understand if the commensal microbiota were responsible for the altered immune responses 
that were mediated during the infection leading to the observed pathogenesis. Interestingly, the 
intestinal microbiota following their transfer, did induce altered immune responses in tissues 
(liver, small intestine, lung) affected by the infection in both the groups of mice. Although the 
inflammatory immune responses were reduced in the resistant and rescued SPF1 and SPF2-
CH C57BL/6 mice respectively for both the small intestine and the lung, the liver on the other 
hand presented a more complex altered immune responses which included reduction in 
eosinophilia, type 2 CD8+ T cell, IL-4 & TNF-α tissue cytokine responses, and increased IL-
13 cytokine response which all support regulation of the liver pathology. Interestingly, the 
regulatory cytokines (IL-10 and TGF-β) were significantly reduced in the liver of SPF1 and 
SPF2-CH C57BL/6 mice, which potentially may have contributed to increased type 1 CD8+ 
T cell (IFN-γ+ CD8+ T cell) response which as reported above in Batf2 model, were 
hypothesised to also contribute to regulation of liver granulomatous immunopathology during 
chronic Schistosomiasis. This further demonstrated the link that exist between the CD8+ T cell 
response and the intestinal microbiota in response to chronic Schistosomiasis.   
The altered immune responses in the affected tissues of the resistant SPF1 and rescued SPF2-
CH C57BL/6 mice respectively, resulted in reduced tissue immunopathology of the liver and 
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the lung, while the tissue immunopathology of the small intestine was significantly reduced. 
Despite the observed small intestinal pathology, there was a reduction in tissue inflammatory 
response while the tissue repairing mediators were increased in these. The resolved tissue 
immunopathology of the mice translated into prolonged survival of the mice during chronic 
Schistosomiasis. This, therefore, proved further that the intestinal microbiota from SPF1 
C57BL/6 mice drive increased protection, while the intestinal microbiota from SPF2 C57BL/6 
mice drive reduced protection during chronic Schistosomiasis. On the other hand, the transfer 
of intestinal microbiota from SPF2-CH C57BL/6 mice also induced altered immune responses 
which resulted in increased tissue immunopathology of the liver and the small intestinal tissue 
in SPF1-CH C57BL/6 mice which ultimately led to premature mortality in relation to SPF1 
C57BL/6 mice. This demonstrated that the SPF2 C57BL/6 mice were harbouring intestinal 
microbiota that compromised the susceptibility of the C57BL/6 mice during chronic 
Schistosomiasis.    
Among the intestinal microbiota, the commensal bacteria constitute a larger number of 
microbiotas in the intestine compared to other microbes (Rapin and Harris, 2018; Tlaskalová-
Hogenová et al., 2011; Sender et al. 2016), and for this reason most microbiome wide 
association studies have mainly focused on these microbes and have demonstrated their 
association with disease complications (Surana and Kasper, 2017; Lynch and Pedersen, 2016). 
It was, therefore, hypothesised that the commensal bacteria were potentially responsible for 
driving the observed pathogenesis in C57BL/6 mice during chronic Schistosomiasis. To test 
this, the SPF1 C57BL/6 mice were treated with a broad-spectrum antibiotic cocktail which 
allowed for the suppression of intestinal bacteria from a composition of protective microbiota. 
This was done to disrupt the transfer of protective commensal microbiota to the susceptible 
SPF2 C57BL/6 mice during chronic Schistosomiasis. Interestingly, however, the transfer of 
intestinal microbiota from the antibiotic treated SPF1-CH C57BL/6 mice was still enough to 
rescue the SPF2-CH C57BL/6 mice during the infection. This, therefore, ruled out the 
influence of commensal bacteria on the pathogenesis of C57BL/6 mice during chronic 
Schistosomiasis.  
The antibiotic cocktail was a large spectrum acting combo selected based on previous data 
which have demonstrated the ability of each compound to effectively reduce broad spectrum 
of bacteria (Marx, et al., 2014; Bayer et al., 2019; Slate et al., 2014; Andes and Craig, 1998; 
Kennedy et al., 2018). Furthermore, in the experiments conducted with the antibiotic treatment 
(Figure 47), there was no complete abrogation of the bacteria since the antibiotic treated SPF1 
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C57BL/6 mice were cohoused with SPF2 C57BL/6 mice which were not antibiotic treated. 
Therefore, even though the antibiotic cocktail were reducing the bacteria, the mice were 
constantly receiving microbiota from the untreated SPF2 C57BL/6 mice. Fortunately, the 
antibiotic treatment was effective enough to keep the bacterial load lower as demonstrated in 
figure 47. But rightfully, the Antibiotic treatment did not effectively limit the protective 
microbe pointing at the need for more diverse depletion approaches (other antibiotic cocktails, 
anti-fungi, anti-viral agents et...) 
 
Of note, the SPF2 C57BL/6 mice were not treated with antibiotic cocktail since the transfer of 
microbiota from SPF2 C57BL/6 mice did not change or increase the susceptibility of the 
protected SPF1 C57BL/6 mice. This, therefore, indicated that there is a transfer of causal 
microbiota (protection) from SPF1 C57BL/6 mice while there was no observable transfer of 
causal microbiota (susceptibility) from SPF2 C57BL/6 mice 
Since it was still unclear which organisms were contributing to improved protection of the 
SPF1 and SPF2 C57BL/6 mice, the intestinal microbiota and serum samples from SPF1 and 
SPF2 C57BL/6 mice were comparatively analysed to identify the differences in commensal 
microbiota compositions that may be contributing to the observed protection. According to the 
report that was generated, organisms including the Helicobacter sp, Murine norovirus (MNV) 
and Pasteurella pneumotropica were found to be present in the resistant SPF1 C57BL/6 mice 
and were not detected in the susceptible SPF2 C57BL/6 mice. Interestingly, one of these 
identified organisms is a virus (Murine norovirus) which has previously been reported to form 
part of commensal microbiota with the potential role of replacing the commensal bacteria for 
their beneficial functions and restoring immune responsiveness in the host they inhabit 
(Kernbauer et al., 2014). Furthermore, they also compensate for the deleterious effects that are 
caused by antibiotic treatment, and therefore play significant compensatory role like that of 
commensal bacteria (Kernbauer et al., 2014). Furthermore, the Murine norovirus were 
demonstrated to drive expansion of IFN-γ+ CD8+ T cell responses among others, which is 
consistent with what is observed in the current study. Given the reported role of the Murine 
norovirus, it therefore, stands to reason that they were potentially contributing to increased 
resistance of SPF2 C57BL/6 mice during chronic Schistosomiasis. However, more studies will 
be needed to explore further and identify the exact roles of these microbes (Murine norovirus) 
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during chronic Schistosomiasis. This will help in strategies employed to generate potential 
therapeutic inventions.  
Even through the study clearly demonstrates the influence of intestinal microbiota on the 
pathogenesis Schistosoma mansoni infected mice, it is still unclear which microbes are 
contributing the protective phenotype. Furthermore, it is only speculated that the microbes may 
potentially be interacting with CD8 expressing populations to induce a protective immune 
response during chronic Schistosomiasis. However, the exact mechanism that the microbes use 
to mediate a protective immune response is still poorly understood and warrants more research 
to explore these mechanisms. The two mouse models used in the study suggest the protective 
phenotype to be driven by causal microbiota that are distinct and potentially unique to each 
model. To fully understand and explore which microbes constitute a protective phenotype in 
both models, a more inclusive approach such whole genome sequencing will be required to 
explore all the microbiota to differentiate between the bacteria, virus, and fungi.   
It is also important to note that all microbiota transfer studies were performed using inbred 
C57BL/6 mice. The use of inbred mice makes our observations less translatable to the human 
situation when compared to the use of outbred mice. However, the use of such a limited 
microbiota as the ones in inbred mice enable might enable a quicker identification of the disease 
regulating microbes from the pool of known commensals. An outbred setting would certainly 
require more power and more experiment to narrow down the observation to a given / group 
of microbe (s). Nevertheless, the validation of our findings in outbred mice is a clear next 
logical step to generalize the proposed concept given their increased genetic and microbiota 
diversity more closely mimicking the elevated diversity in the human population (Tuttle et al., 
2018) than inbred mice.  
Interactome and resistance to chronic Schistosomiasis 
Among the host’s protective mechanisms that are induced during Schistosomiasis there exist 
CD8+ T cell-driven mechanism which is still poorly understood; however, it appears that 
different subsets of the population induce varying roles with the type 1 CD8+ T cells being 
demonstrated to contribute to regulated liver granulomatous immunopathology during S. 
mansoni infection through the production of IFN-γ (Pedras-Vasconcelos et al., 1996; Pancreâ 
et al., 1999). Interestingly, the studies have demonstrated that the SEA favours induction of the 
CD8+ T cell subsets than other cell types (Fallon et a., 1998; Pancreâ et al., 1999; Pedras-
Vasconcelos et al., 1996). On the other hand, the role of other subsets of CD8+ T cells such 
 
113 | P a g e  
 
type 2 CD8+ T cells, during Schistosomiasis is poorly understood. The type 2 CD8+ T cells 
are responsible for the production of inflammatory type 2 cytokines such IL-4, 5, and 13 (Fallon 
et a., 1998). Our data demonstrate that these type 2 subsets of CD8+ T cells may be contributing 
to increased inflammatory immune response as we have evidenced an increase type 2 CD8+ T 
cells in the susceptible SPF2 C57BL/6 mice during chronic Schistosomiasis (Figure 38). These 
would need to be further explored and may not be SEA specific but rather a result of altered 
intestinal microbiota. Therefore, the CD8+ T cells are either good or potentially bad during 
chronic Schistosomiasis depending on the subset they polarize into upon their activation during 
the infection. This is similar to what is observed with the CD4+ T cell polarization during 
infection. When the CD4+ T cells polarize into Th2 subsets during Schistosomiasis, they drive 
increased granulomatous inflammatory immune responses that help neutralize the pathogenic 
schistosomiasis eggs, and such a response can be pathogenic to host if not controlled (Hams et 
al., 2013). To prevent this, the host also induces Foxp3+ CD4+ T cells which help regulate 
against exacerbated Th2 immune responses during Schistosomiasis (Baumgart et al., 2006). 
Therefore, similar to CD4+ T cells taking different phenotypes to control the infection, the 
CD8+ T cells also follow the same polarization diversity resulting in different subsets with 
varying roles during the infection. 
In line with this, the foxp3+ CD8+ T cells were also explored during chronic Schistosomiasis. 
These cells are a unique population in that they can recognize antigens presented by cells with 
both MHC-I and MHC-II molecules, (Flippe et al., 2019). This gives them the advantage of 
being able to have suppressive effects on all cells, unlike the Foxp3-expressing CD4+ T cells 
which only have suppressive effects on cells expressing MHC-II molecules (Flippe et al., 
2019). Therefore, the recruitment of Foxp3-expressing CD8+ T cells is vital in the current study 
in that they can induce their suppressive effects on all inflammatory immune populations that 
expresses both MHC-I and MHC-II molecules which may have potentially been activated by 
the intestinal microbiota. The resistant mice (Baft2-/-, WT-CH, SPF1 C57BL/6, SPF2-CH 
C57BL/6 mice) all maintained increased recruitment of these cells which potentially have also 
contributed to their survival during chronic Schistosomiasis. 
The data presented in the current study demonstrated the ability of the host genetic factor 
(Batf2) to influence the intestinal microbiota composition which in turn also influences the host 
immune responses. The changes in these components resulted in regulated immunopathology 
and ultimately improved survival of mice during chronic Schistosomiasis. This highlighted an 
important interrelationship that exist between host genetic factor (Batf2), microbiota, and the 
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immune system during Schistosomiasis. Considering this, it therefore, stands to reason that, 
the use of microbiota together with host components such as IL-4 or Batf2, as well as key 
immune populations that might have a direct link with the microbes (i.e., CD8 expressing cells) 
could provide a strong approach for the control of infections and their resultant 
immunopathology. The present work is a proof of concept of this existing tripartite regulation 
of chronic schistosomiasis progression and calls for more multilevel considerations in future 
investigations of the regulation of this debilitating disease. 
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